| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.50e-05 | 5 | 231 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | protein kinase activity | MYLK EPHA6 RPS6KA5 CDK19 INSR MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK BRD2 CDK13 PAK3 LYN EPHA5 | 7.55e-05 | 600 | 231 | 19 | GO:0004672 |
| GeneOntologyMolecularFunction | protein domain specific binding | ADAM9 INSR PTPN22 SYNGAP1 HOXA3 LDB1 UBR5 MYPN ZBTB21 SIGLEC10 BAIAP2 NIPBL DTNA ZNF521 E2F4 DENND1A CASK TJP1 HGS PAK3 LYN ICA1L INPP5J TP53 | 8.32e-05 | 875 | 231 | 24 | GO:0019904 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MYLK RPS6KA5 CDK19 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK BRD2 CDK13 PAK3 | 2.30e-04 | 446 | 231 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MYLK EPHA6 RPS6KA5 CDK19 INSR PFKFB2 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK BRD2 CDK13 PAK3 LYN EPHA5 | 2.30e-04 | 709 | 231 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | SH3 domain binding | 2.65e-04 | 143 | 231 | 8 | GO:0017124 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | RPS6KA5 CDK19 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 | 3.31e-04 | 363 | 231 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | alpha-actinin binding | 4.30e-04 | 31 | 231 | 4 | GO:0051393 | |
| GeneOntologyMolecularFunction | protein kinase binding | ADAM9 INSR PTPN22 PFKFB2 NEK9 MEF2A SYNGAP1 AURKA PTPN14 TAOK1 CDK5R2 DPYSL2 APC DOK2 CASK CDK13 SIPA1L1 PITPNM3 POTEJ ATP1B1 RFPL2 TP53 | 5.32e-04 | 873 | 231 | 22 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase activity | MYLK EPHA6 RPS6KA5 CDK19 INSR PFKFB2 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK BRD2 CDK13 PAK3 LYN EPHA5 | 5.97e-04 | 764 | 231 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | muscle alpha-actinin binding | 6.27e-04 | 15 | 231 | 3 | GO:0051371 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | RPL29 GAPVD1 GLDN UBAP2 ADAM9 ITGA6 CC2D1A CDHR5 MYPN TLN2 BAIAP2 DNAJB1 APC ADGRL1 TJP1 LYN HDLBP | 6.36e-04 | 599 | 231 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | histone H3S10 kinase activity | 7.87e-04 | 4 | 231 | 2 | GO:0035175 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | KDM5B TBL1Y BCLAF1 KDM3B EWSR1 BCL9 TRIP11 PTPN14 LDB1 NIPBL NPAT DNAJB1 GPS2 NCOA5 KDM7A LCOR | 8.85e-04 | 562 | 231 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | kinase binding | ADAM9 INSR PTPN22 PFKFB2 NEK9 MEF2A SYNGAP1 AURKA PTPN14 TAOK1 CDK5R2 DPYSL2 APC DOK2 CASK CDK13 SIPA1L1 PITPNM3 POTEJ ATP1B1 RFPL2 TP53 HTT | 8.98e-04 | 969 | 231 | 23 | GO:0019900 |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 1.30e-03 | 5 | 231 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MYLK EPHA6 RPS6KA5 CDK19 INSR PFKFB2 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 PRIMPOL CAMK2G MINK1 TEP1 CASK BRD2 CDK13 PAK3 LYN EPHA5 | 1.35e-03 | 938 | 231 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | actinin binding | 1.51e-03 | 43 | 231 | 4 | GO:0042805 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 GLDN PSD EPHA6 RPS6KA5 MAP6 ITGA6 CC2D1A TRIP11 MEF2A SYNGAP1 AURKA PTPRS MYPN COBL TAOK1 BAIAP2 NYAP1 CDK5R2 RPGRIP1 DPYSL2 CAMK2G MINK1 APC TRIOBP GPRIN3 APOD CASK PLEKHG4B PPP2R5D CELSR2 MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ LYN INPP5J HTT EPHA5 | 9.97e-08 | 1463 | 229 | 40 | GO:0048666 |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 1.79e-07 | 38 | 229 | 7 | GO:0071539 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 2.16e-07 | 39 | 229 | 7 | GO:1905508 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 PSD EPHA6 RPS6KA5 MAP6 ITGA6 CC2D1A TRIP11 MEF2A SYNGAP1 AURKA PTPRS MYPN COBL BAIAP2 NYAP1 CDK5R2 DPYSL2 CAMK2G MINK1 APC TRIOBP GPRIN3 APOD CASK PLEKHG4B PPP2R5D CELSR2 MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ LYN INPP5J EPHA5 | 2.68e-07 | 1285 | 229 | 36 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 EPHA6 RPS6KA5 MAP6 CC2D1A MEF2A SYNGAP1 PTPRS MYPN COBL BAIAP2 CDK5R2 MINK1 APC TRIOBP CASK PLEKHG4B CELSR2 MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ EPHA5 | 3.34e-06 | 748 | 229 | 24 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 EPHA6 RPS6KA5 MAP6 CC2D1A MEF2A SYNGAP1 AURKA PTPRS MYPN COBL BAIAP2 NYAP1 CDK5R2 MINK1 APC CASK PLEKHG4B CELSR2 MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ EPHA5 | 3.43e-06 | 802 | 229 | 25 | GO:0048812 |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 3.96e-06 | 59 | 229 | 7 | GO:0072698 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 EPHA6 RPS6KA5 MAP6 CC2D1A MEF2A SYNGAP1 AURKA PTPRS MYPN COBL BAIAP2 NYAP1 CDK5R2 MINK1 APC CASK PLEKHG4B CELSR2 MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ EPHA5 | 4.95e-06 | 819 | 229 | 25 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 EPHA6 RPS6KA5 MAP6 CC2D1A MEF2A SYNGAP1 AURKA PTPRS MYPN COBL BAIAP2 NYAP1 CDK5R2 MINK1 APC CASK PLEKHG4B CELSR2 MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ EPHA5 | 5.74e-06 | 826 | 229 | 25 | GO:0048858 |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 6.19e-06 | 63 | 229 | 7 | GO:0044380 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | TANC2 MAP6 CC2D1A MEF2A BAIAP2 MINK1 CASK CELSR2 SIPA1L1 PAK3 EPHA5 | 1.40e-05 | 198 | 229 | 11 | GO:0048813 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCP110 HAUS6 INCENP MAP6 CC2D1A CEP350 AURKA STARD9 TAOK1 MTCL1 CHMP4C SLAIN2 APC E2F4 SPECC1L C2CD3 PDE4DIP FMN2 CEP131 INPP5J PCM1 HTT | 1.86e-05 | 720 | 229 | 22 | GO:0000226 |
| GeneOntologyBiologicalProcess | dendrite development | TANC2 MAP6 CC2D1A MEF2A SYNGAP1 PTPRS COBL BAIAP2 MINK1 CASK CELSR2 SIPA1L1 PAK3 EPHA5 | 2.45e-05 | 335 | 229 | 14 | GO:0016358 |
| GeneOntologyBiologicalProcess | non-motile cilium assembly | 2.57e-05 | 78 | 229 | 7 | GO:1905515 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | CCP110 HAUS6 CC2D1A AURKA CHMP4C E2F4 C2CD3 PDE4DIP CEP131 PCM1 | 3.29e-05 | 179 | 229 | 10 | GO:0031023 |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 4.60e-05 | 36 | 229 | 5 | GO:0007274 | |
| GeneOntologyBiologicalProcess | postsynapse organization | TANC2 PSD RPS6KA5 INSR CC2D1A SYNGAP1 PTPRS BAIAP2 CASK SIPA1L1 PAK3 POTEJ EPHA5 | 5.10e-05 | 313 | 229 | 13 | GO:0099173 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | CCP110 HAUS6 SYNPO2 PSD CC2D1A PTPN22 SH3YL1 LDB1 PTPRS COBL BAIAP2 FNIP2 CHMP4C SLAIN2 DNAJB1 APC TRIOBP ADGRL1 APOD RESF1 TJP1 SIPA1L1 HGS PDE4DIP PAK3 SLX4 INPP5J TP53 HTT | 5.79e-05 | 1189 | 229 | 29 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 EPHA6 RPS6KA5 MAP6 CC2D1A MEF2A SYNGAP1 AURKA PTPRS MYPN COBL PDZD8 BAIAP2 NYAP1 CDK5R2 COL27A1 MINK1 APC TRIOBP CASK PLEKHG4B CELSR2 MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ LYN EPHA5 | 6.23e-05 | 1194 | 229 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 PSD RPS6KA5 INSR ITGA6 CC2D1A SYNGAP1 LDB1 PTPRS TLN2 BAIAP2 OCEL1 PCLO APC ADGRL1 SPECC1L APOD CASK XIRP2 TJP1 SIPA1L1 PAK3 POTEJ NPAS4 EPHA5 | 8.78e-05 | 974 | 229 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | centrosome cycle | 9.35e-05 | 164 | 229 | 9 | GO:0007098 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 1.60e-04 | 176 | 229 | 9 | GO:0070507 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CCP110 HAUS6 SYNPO2 INCENP MAP6 INSR AURKA PTPRS TAOK1 BAIAP2 PMAIP1 CHMP4C SLAIN2 APC TRIOBP SPECC1L PRDM7 RESF1 WDHD1 XIRP2 TJP1 SIPA1L1 PDE4DIP PAK3 EIF4G3 SLX4 INPP5J TP53 HTT EPHA5 | 2.01e-04 | 1342 | 229 | 30 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 2.05e-04 | 108 | 229 | 7 | GO:0031110 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHA6 RPS6KA5 MAP6 SYNGAP1 PTPRS MYPN COBL BAIAP2 CDK5R2 APC PLEKHG4B MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ EPHA5 | 2.08e-04 | 566 | 229 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 2.32e-04 | 185 | 229 | 9 | GO:0099175 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 2.84e-04 | 81 | 229 | 6 | GO:0060997 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 3.01e-04 | 115 | 229 | 7 | GO:0097061 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CCP110 HAUS6 INCENP MAP6 CC2D1A CEP350 AURKA STARD9 TAOK1 MTCL1 CHMP4C SLAIN2 APC E2F4 SPECC1L C2CD3 CELSR2 MEGF8 PDE4DIP FMN2 CEP131 INPP5J PCM1 HTT INVS | 3.13e-04 | 1058 | 229 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | axon development | EPHA6 RPS6KA5 MAP6 SYNGAP1 PTPRS MYPN COBL BAIAP2 CDK5R2 APC APOD PLEKHG4B MEGF8 SIPA1L1 PAK3 KIAA1755 POTEJ EPHA5 | 3.14e-04 | 642 | 229 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 3.28e-04 | 54 | 229 | 5 | GO:0048013 | |
| GeneOntologyCellularComponent | actin cytoskeleton | SYNPO2 MYLK MYO7B PDLIM7 COBL TLN2 BAIAP2 TRIOBP SPECC1L CASK NCOA5 XIRP2 TJP1 SIPA1L1 LPP FMN2 POTEJ | 2.19e-04 | 576 | 229 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | spindle | HAUS6 INCENP TBL1Y CEP350 AURKA MTUS1 MTCL1 CHMP4C DIDO1 SPECC1L CKAP2L FMN2 MAPKBP1 CSPP1 INVS | 2.31e-04 | 471 | 229 | 15 | GO:0005819 |
| GeneOntologyCellularComponent | manchette | 2.34e-04 | 28 | 229 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 3.66e-04 | 56 | 229 | 5 | GO:0099091 | |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 PSD CHRM1 SYNGAP1 AURKA PTPRS BAIAP2 DNAJB1 DPYSL2 CAMK2G PCLO MINK1 SIPA1L1 PAK3 LYN | 4.61e-04 | 503 | 229 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | ruffle | 4.64e-04 | 206 | 229 | 9 | GO:0001726 | |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 PSD CHRM1 SYNGAP1 AURKA PTPRS BAIAP2 DNAJB1 DPYSL2 CAMK2G PCLO MINK1 SIPA1L1 PAK3 | 4.80e-04 | 451 | 229 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | microtubule organizing center | CCP110 HAUS6 CC2D1A NEK9 CEP350 AURKA MTUS1 STARD9 FNIP2 SLAIN2 APC TRIOBP SPECC1L C2CD3 RESF1 PDE4DIP CKAP2L CEP131 CSPP1 PCM1 TP53 HTT | 5.11e-04 | 919 | 229 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | dendrite | TANC2 PSD EPHA6 MAP6 INSR CHRM1 SYNGAP1 COBL BAIAP2 DNAJB1 DPYSL2 PCLO MINK1 APC APOD DENND1A CASK SIPA1L1 INPP5J HTT EPHA5 | 5.15e-04 | 858 | 229 | 21 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 PSD EPHA6 MAP6 INSR CHRM1 SYNGAP1 COBL BAIAP2 DNAJB1 DPYSL2 PCLO MINK1 APC APOD DENND1A CASK SIPA1L1 INPP5J HTT EPHA5 | 5.31e-04 | 860 | 229 | 21 | GO:0097447 |
| GeneOntologyCellularComponent | centriole | 6.35e-04 | 172 | 229 | 8 | GO:0005814 | |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 PSD CHRM1 SYNGAP1 AURKA PTPRS BAIAP2 DNAJB1 DPYSL2 CAMK2G PCLO MINK1 SIPA1L1 PAK3 | 8.29e-04 | 477 | 229 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | axon | TANC2 GLDN MAP6 INSR CHRM1 AURKA KCNQ5 PTPRS MYPN COBL CDK5R2 DPYSL2 DTNA PCLO MINK1 APC ADGRL1 POTEJ INPP5J HTT EPHA5 | 8.35e-04 | 891 | 229 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | anchoring junction | SYNPO2 MYLK PDLIM7 ADAM9 ITGA6 MAST2 TLN2 BAIAP2 OCEL1 APC TRIOBP SPECC1L CASK PLEKHG4B XIRP2 TJP1 MDC1 LPP ATP1B1 LYN PCDH1 EPHA5 | 1.12e-03 | 976 | 229 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | integrator complex | 1.49e-03 | 21 | 229 | 3 | GO:0032039 | |
| Domain | SH3_2 | 1.09e-05 | 86 | 230 | 8 | PF07653 | |
| Domain | SH3_2 | 1.09e-05 | 86 | 230 | 8 | IPR011511 | |
| Domain | PROTEIN_KINASE_ATP | MYLK EPHA6 RPS6KA5 CDK19 INSR MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 LYN EPHA5 | 1.64e-05 | 459 | 230 | 18 | PS00107 |
| Domain | Prot_kinase_dom | MYLK EPHA6 RPS6KA5 CDK19 INSR MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 LYN EPHA5 | 3.78e-05 | 489 | 230 | 18 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MYLK EPHA6 RPS6KA5 CDK19 INSR MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 LYN EPHA5 | 4.20e-05 | 493 | 230 | 18 | PS50011 |
| Domain | PDZ | 1.08e-04 | 151 | 230 | 9 | PS50106 | |
| Domain | PDZ | 1.14e-04 | 152 | 230 | 9 | IPR001478 | |
| Domain | Kinase-like_dom | MYLK EPHA6 RPS6KA5 CDK19 INSR MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 LYN EPHA5 | 1.40e-04 | 542 | 230 | 18 | IPR011009 |
| Domain | Ser/Thr_kinase_AS | MYLK RPS6KA5 CDK19 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 | 1.45e-04 | 357 | 230 | 14 | IPR008271 |
| Domain | DM14 | 1.51e-04 | 2 | 230 | 2 | SM00685 | |
| Domain | DM14 | 1.51e-04 | 2 | 230 | 2 | IPR006608 | |
| Domain | S_TKc | MYLK RPS6KA5 CDK19 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 | 1.54e-04 | 359 | 230 | 14 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MYLK RPS6KA5 CDK19 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 | 1.68e-04 | 362 | 230 | 14 | PS00108 |
| Domain | FN3 | MYLK EPHA6 INSR PTPRS RIMBP3C IGDCC3 RIMBP3 RIMBP3B IL6R EPHA5 | 1.85e-04 | 199 | 230 | 10 | PS50853 |
| Domain | Protein_kinase_ATP_BS | MYLK EPHA6 RPS6KA5 CDK19 INSR AURKA TLK1 TAOK1 CAMK2G MINK1 CDK13 PAK3 LYN EPHA5 | 2.68e-04 | 379 | 230 | 14 | IPR017441 |
| Domain | FN3_dom | MYLK EPHA6 INSR PTPRS RIMBP3C IGDCC3 RIMBP3 RIMBP3B IL6R EPHA5 | 2.75e-04 | 209 | 230 | 10 | IPR003961 |
| Domain | Pkinase | MYLK RPS6KA5 CDK19 MAST2 NEK9 AURKA TLK1 MAST4 TAOK1 CAMK2G MINK1 CASK CDK13 PAK3 | 2.83e-04 | 381 | 230 | 14 | PF00069 |
| Domain | SH3 | MYO7B RUSC2 SH3YL1 RIMBP3C BAIAP2 CASK RIMBP3 TJP1 RIMBP3B LYN | 3.58e-04 | 216 | 230 | 10 | SM00326 |
| Domain | SH3 | MYO7B RUSC2 SH3YL1 RIMBP3C BAIAP2 CASK RIMBP3 TJP1 RIMBP3B LYN | 3.58e-04 | 216 | 230 | 10 | PS50002 |
| Domain | PDZ | 3.64e-04 | 141 | 230 | 8 | PF00595 | |
| Domain | SH3_domain | MYO7B RUSC2 SH3YL1 RIMBP3C BAIAP2 CASK RIMBP3 TJP1 RIMBP3B LYN | 4.14e-04 | 220 | 230 | 10 | IPR001452 |
| Domain | Znf_PHD-finger | 4.29e-04 | 79 | 230 | 6 | IPR019787 | |
| Domain | FGF1-bd | 4.49e-04 | 3 | 230 | 2 | IPR010510 | |
| Domain | FGF-BP1 | 4.49e-04 | 3 | 230 | 2 | PF06473 | |
| Domain | Znf_FYVE_PHD | 4.81e-04 | 147 | 230 | 8 | IPR011011 | |
| Domain | FN3 | 4.91e-04 | 185 | 230 | 9 | SM00060 | |
| Domain | PDZ | 5.03e-04 | 148 | 230 | 8 | SM00228 | |
| Domain | - | 5.50e-04 | 150 | 230 | 8 | 2.30.42.10 | |
| Domain | PHD | 8.11e-04 | 89 | 230 | 6 | SM00249 | |
| Domain | DUF1908 | 8.91e-04 | 4 | 230 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 8.91e-04 | 4 | 230 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 8.91e-04 | 4 | 230 | 2 | IPR023142 | |
| Domain | - | 8.91e-04 | 4 | 230 | 2 | 1.20.1480.20 | |
| Domain | Znf_PHD | 9.11e-04 | 91 | 230 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.14e-03 | 95 | 230 | 6 | PS50016 | |
| Domain | C2 | 1.20e-03 | 131 | 230 | 7 | PF00168 | |
| Domain | ZF_PHD_1 | 1.20e-03 | 96 | 230 | 6 | PS01359 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 TET2 CCP110 KDM5B GAPVD1 UBAP2 EMC1 KDM3B CC2D1A PFKFB2 MAST2 TRIP11 FAM53C NEK9 RUSC2 CEP350 USP31 PTPN14 MAST4 KCNQ5 MTUS1 STARD9 ZBTB21 COBL MTCL1 BAIAP2 SLAIN2 DNAJB1 MINK1 APC RFX7 DENND1A C2CD3 RESF1 MEGF8 TJP1 SIPA1L1 LPP FMN2 CEP131 EIF4G3 CSPP1 PCM1 TP53 | 7.43e-26 | 861 | 234 | 44 | 36931259 |
| Pubmed | TANC2 UBAP2 MAP6 TBL1Y BCLAF1 ADAM9 EWSR1 BCL9 TRIP11 NEK9 SYNGAP1 LDB1 UBR5 PTPRS ZBTB21 TLN2 MTCL1 TAF4 BAIAP2 PRRC2A NIPBL DPYSL2 CAMK2G MINK1 APC TRIOBP DIDO1 SPECC1L CASK PPP2R5D ZC2HC1A CELSR2 TJP1 SIPA1L1 PDE4DIP PAK3 CEP131 PCM1 | 1.54e-18 | 963 | 234 | 38 | 28671696 | |
| Pubmed | EMC1 LEMD3 PDLIM7 ITGA6 PSMD2 PTPN22 CEP350 USP31 PTPN14 MTUS1 PTPRS KIAA1328 PHLPP1 PDZD8 BAIAP2 PRRC2A DNAJB1 RELCH PMS2 DTNA TMEM51 MINK1 ZNF280C TRIOBP GPRIN3 SRFBP1 RCAN3 CASK NCOA5 C2CD3 PPP2R5D BRD2 TJP1 HGS LPP FMN2 CEP131 CSPP1 HDLBP | 3.91e-18 | 1049 | 234 | 39 | 27880917 | |
| Pubmed | HAUS6 GAPVD1 UBAP2 PDLIM7 BCLAF1 KDM3B CC2D1A NEK9 BRAP PTPN14 CIZ1 TAF4 PRRC2A SLAIN2 DNAJB1 DPYSL2 EP400 DIDO1 SPECC1L GTF2I GTF3C1 TJP1 MDC1 LPP PCM1 TP53 HTT HDLBP | 1.17e-16 | 549 | 234 | 28 | 38280479 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KCNH8 EPHA6 CDK19 INSR INTS3 NEK9 MEF2A SH3YL1 TLK1 LDB1 KCNQ5 INTS2 PTPRS SUPT6H KIAA1328 COBL TAF4 BAIAP2 DPYSL2 DTNA WWP1 MINK1 TRIOBP ADGRL1 TEP1 DENND1A CASK PLEKHG4B GTF2I GTF3C1 TJP1 CDK13 LPP PAK3 EIF4G3 PCDH1 LCOR ICA1L IL6R PCM1 HTT INVS | 3.00e-15 | 1489 | 234 | 42 | 28611215 |
| Pubmed | RPL29 HAUS6 GAPVD1 ACACB INCENP LEMD3 BCLAF1 INSR UTP14A KDM3B CC2D1A TRIP11 CEP350 UBR5 DCLRE1A BAIAP2 SLAIN2 SFSWAP EP400 MINK1 APC GPRIN3 SPECC1L PKHD1L1 CASK GTF2I TJP1 CEP131 EIF4G3 PCM1 | 1.51e-14 | 777 | 234 | 30 | 35844135 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HAUS6 GAPVD1 ACACB PDLIM7 CC2D1A MAST2 GFPT1 CEP350 PTPN14 MAST4 MTUS1 UBR5 BRPF1 SIMC1 COBL BAIAP2 CPLANE1 SLAIN2 DPYSL2 APC PAIP1 RIMBP3 C2CD3 PPP2R5D ZC2HC1A TJP1 SIPA1L1 HGS LYN PCM1 TP53 | 2.68e-14 | 853 | 234 | 31 | 28718761 |
| Pubmed | TANC2 CCP110 GAPVD1 ACACB PDLIM7 PFKFB2 MAST2 AURKA PTPN14 UBR5 NYNRIN MTCL1 BAIAP2 DNAJB1 APC DENND1A PPP2R5D TJP1 SIPA1L1 HGS CEP131 CSPP1 PCM1 | 5.69e-14 | 446 | 234 | 23 | 24255178 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GAPVD1 RPS6KA5 BCLAF1 KDM3B BCL9 INTS3 FAM53C TLK1 BRPF1 ZBTB21 TLN2 TAOK1 PRRC2A NIPBL DHX16 SFSWAP EP400 MINK1 DIDO1 RFX7 GTF2I BRD2 GTF3C1 WDHD1 CDK13 SIPA1L1 MDC1 PCM1 HDLBP | 9.11e-14 | 774 | 234 | 29 | 15302935 |
| Pubmed | TET2 KDM5B ADAM9 USP25 PSMD2 EWSR1 TRIP11 FAM53C GFPT1 SH3YL1 SYNGAP1 CEP350 LDB1 PDZD8 TLN2 TAOK1 BAIAP2 PRRC2A NIPBL NR1D2 DPYSL2 PMS2 APC ZNF521 TRIOBP CASK BRD2 TJP1 SIPA1L1 PDE4DIP FMN2 ANKRD36 EIF4G3 LCOR SLX4 PCM1 | 4.50e-13 | 1285 | 234 | 36 | 35914814 | |
| Pubmed | TANC2 RPL29 UBAP2 EMC1 ACACB MAP6 BCLAF1 PSMD2 NACAD SYNGAP1 KCNQ5 TLN2 BAIAP2 RELCH DPYSL2 DTNA CAMK2G PCLO MINK1 APC TRIOBP ADGRL1 PPP2R5D CELSR2 TJP1 SIPA1L1 PDE4DIP PITPNM3 PAK3 CEP131 EIF4G3 PCM1 HDLBP | 1.92e-12 | 1139 | 234 | 33 | 36417873 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL29 GAPVD1 EMC1 PDLIM7 BCLAF1 INSR UTP14A PSMD2 EWSR1 CEP350 UBR5 SUPT6H ZBTB21 CIZ1 HEATR5B NIPBL DHX16 EP400 SPECC1L NCOA5 BRD2 GTF3C1 TJP1 MDC1 CKAP2L CEP131 ATP1B1 LYN PCM1 TP53 HDLBP | 3.15e-12 | 1024 | 234 | 31 | 24711643 |
| Pubmed | TANC2 PSMD2 RUSC2 SYNGAP1 TAOK1 BAIAP2 PRRC2A DPYSL2 CAMK2G PCLO MINK1 APC ADGRL1 SIPA1L1 PITPNM3 FMN2 EIF4G3 PCM1 HTT | 3.38e-12 | 347 | 234 | 19 | 17114649 | |
| Pubmed | CCP110 HAUS6 BCLAF1 CC2D1A GFPT1 MYPN TLN2 TAOK1 MTCL1 PRRC2A NIPBL DPYSL2 PMS2 APC DIDO1 GTF2I ZC2HC1A GTF3C1 CDK13 CEP131 EIF4G3 PCM1 | 5.35e-12 | 503 | 234 | 22 | 16964243 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL29 HAUS6 GAPVD1 UBAP2 ACACB BCLAF1 UTP14A KDM3B CC2D1A TRIP11 NEK9 GFPT1 BRAP ZBTB21 CIZ1 PRRC2A NIPBL DNAJB1 DPYSL2 EP400 ZNF280C DIDO1 GTF2I TJP1 LPP EIF4G3 PCM1 TP53 HDLBP | 9.16e-12 | 934 | 234 | 29 | 33916271 |
| Pubmed | TET2 SP4 BCLAF1 KDM3B CC2D1A PTPN22 EWSR1 BCL9 MEF2A AURKA TLK1 UBR5 ZBTB21 TAF4 PRRC2A NIPBL SLAIN2 DNAJB1 EP400 BAZ2B CAMK2G GPS2 DIDO1 GTF2I RESF1 GTF3C1 CDK13 LCOR PCM1 TP53 HDLBP | 2.06e-11 | 1103 | 234 | 31 | 34189442 | |
| Pubmed | EMC1 LEMD3 TBL1Y PDLIM7 UTP14A AURKA INTS2 SUPT6H RECQL5 GORAB CIZ1 TAF4 BAIAP2 HEATR5B PRRC2A NIPBL SLAIN2 DNAJB1 SFSWAP EP400 MINK1 APC TRIOBP DIDO1 SPECC1L SRFBP1 DENND1A CASK BRD2 CDK13 SIPA1L1 MDC1 CEP131 EIF4G3 ATP1B1 HDLBP | 3.49e-11 | 1497 | 234 | 36 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UBAP2 INCENP LEMD3 BCLAF1 UTP14A EWSR1 RECQL5 SIMC1 CIZ1 TAF4 PRRC2A NIPBL NPAT SFSWAP EP400 BAZ2B ZNF280C DIDO1 SRFBP1 GTF2I BRD2 TJP1 MDC1 LCOR SLX4 PCM1 TP53 HDLBP | 7.85e-11 | 954 | 234 | 28 | 36373674 |
| Pubmed | TET2 GAPVD1 UBAP2 EMC1 BCLAF1 KDM3B NACAD MAST4 INTS2 MTUS1 SUPT6H ZBTB21 SLAIN2 RELCH EP400 ZNF280C TRIOBP DIDO1 MDC1 KDM7A LCOR | 9.94e-11 | 529 | 234 | 21 | 14621295 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP4 SYNPO2 UBAP2 ACACB PDLIM7 PTPN22 BCL9 NEK9 SYNGAP1 ZNF469 NYAP1 EP400 PAIP1 PLEKHG4B XIRP2 UBQLN3 MDC1 EIF4G3 TP53 | 1.34e-10 | 430 | 234 | 19 | 35044719 |
| Pubmed | TET2 UBAP2 ACACB TBL1Y UTP14A PSMD2 CC2D1A EWSR1 BCL9 MEF2A LDB1 RECQL5 ZBTB21 TAF4 PRRC2A NIPBL NPAT EP400 DTNA GPS2 ZNF521 DIDO1 RFX7 GTF2I RESF1 BRD2 GTF3C1 TTC31 MDC1 HGS CEP131 SLX4 PCM1 TP53 | 1.73e-10 | 1429 | 234 | 34 | 35140242 | |
| Pubmed | CCP110 GAPVD1 CEP350 MAST4 MTUS1 UBR5 MYPN COBL MTCL1 APC SIPA1L1 LPP CEP131 PCM1 | 1.85e-10 | 209 | 234 | 14 | 36779422 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | RPL29 HAUS6 UTP14A CEP350 KRBA1 UBR5 DCLRE1A SLAIN2 C2CD3 TJP1 SIPA1L1 CEP131 PCM1 | 4.33e-10 | 184 | 234 | 13 | 32908313 |
| Pubmed | ACACB LEMD3 INSR ITGA6 TRIP11 USP31 PTPN14 GORAB COBL DTNA TMEM51 MINK1 TRIOBP ADGRL1 GPRIN3 CASK CELSR2 HGS | 7.05e-10 | 421 | 234 | 18 | 36976175 | |
| Pubmed | KCNH8 HSPA12B NEK9 NACAD KCNQ5 STARD9 NYNRIN GORAB PHF21B PRDM7 RESF1 XIRP2 PDE4DIP ICA1L | 7.69e-10 | 233 | 234 | 14 | 37704626 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HAUS6 UBAP2 PDLIM7 BCLAF1 UTP14A CC2D1A CEP350 BRPF1 DCLRE1A BAIAP2 PRRC2A DNAJB1 DPYSL2 CAMK2G MINK1 APC TRIOBP C16orf96 SPECC1L TJP1 EIF4G3 LCOR HDLBP | 9.57e-10 | 724 | 234 | 23 | 36232890 |
| Pubmed | CCP110 GAPVD1 UBAP2 LEMD3 KDM3B BRAP CEP350 PDZD8 DCLRE1A BAIAP2 DPYSL2 EP400 APC PAIP1 RCAN3 PPP2R5D WDHD1 TJP1 MDC1 HGS LPP CEP131 PCM1 | 1.21e-09 | 733 | 234 | 23 | 34672954 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HAUS6 GAPVD1 INCENP LEMD3 PDLIM7 BCLAF1 INSR NEK9 CEP350 AURKA TLK1 UBR5 MYPN CIZ1 TLN2 MTCL1 NIPBL DHX16 SLAIN2 DNAJB1 APC TRIOBP PPP2R5D GTF2I GTF3C1 TJP1 CEP131 SLX4 PCM1 | 1.30e-09 | 1155 | 234 | 29 | 20360068 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TANC2 CCP110 HAUS6 GAPVD1 PDLIM7 BCLAF1 UTP14A KDM3B CC2D1A FAM53C NEK9 MEF2A RUSC2 CEP350 AURKA UBR5 MYPN HEATR5B DHX16 CHMP4C SLAIN2 GPS2 DENND1A ZC2HC1A WDHD1 TJP1 LPP | 2.39e-09 | 1038 | 234 | 27 | 26673895 |
| Pubmed | 3.12e-09 | 107 | 234 | 10 | 11347906 | ||
| Pubmed | GAPVD1 INCENP UTP14A PSMD2 EWSR1 GFPT1 UBR5 SUPT6H PRRC2A NIPBL DHX16 DPYSL2 DIDO1 GTF2I GTF3C1 TJP1 MDC1 EIF4G3 PCM1 TP53 HDLBP | 4.30e-09 | 653 | 234 | 21 | 22586326 | |
| Pubmed | CCP110 HAUS6 CEP350 AURKA SLAIN2 C2CD3 PDE4DIP CKAP2L CEP131 CSPP1 PCM1 | 4.98e-09 | 146 | 234 | 11 | 21399614 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | MAP6 ADAM9 SYNGAP1 UBR5 TLN2 BAIAP2 DPYSL2 CAMK2G PCLO MINK1 SPECC1L SIPA1L1 ATP1B1 PCDH1 | 8.54e-09 | 281 | 234 | 14 | 28706196 |
| Pubmed | ADAM9 CDK19 RUSC2 USP31 UBR5 STARD9 COBL MTCL1 FNIP2 DHX16 EP400 ADGRL1 MEGF8 SIPA1L1 PDE4DIP MAPKBP1 | 2.08e-08 | 407 | 234 | 16 | 12693553 | |
| Pubmed | CCP110 HAUS6 BRAP UFD1 GPRIN3 E2F4 TJP1 HGS CEP131 CSPP1 PCM1 | 2.30e-08 | 169 | 234 | 11 | 31462741 | |
| Pubmed | EMC1 ACACB LEMD3 PDLIM7 ADAM9 CC2D1A EWSR1 BCL9 TRIP11 AURKA HEBP1 UFD1 GORAB PDZD8 BAIAP2 DHX16 SLAIN2 DPYSL2 GPS2 NCOA5 WDHD1 TJP1 SIPA1L1 LPP PCM1 | 2.42e-08 | 1007 | 234 | 25 | 34597346 | |
| Pubmed | TET2 KDM5B HAUS6 GAPVD1 ACACB NEK9 UBR5 ZBTB21 NPAT CAMK2G APC GTF2I RESF1 GTF3C1 CEP131 PCM1 | 3.00e-08 | 418 | 234 | 16 | 34709266 | |
| Pubmed | KDM5B SP4 KDM3B MEF2A KRBA1 LDB1 BRPF1 ZBTB21 CIZ1 KLF17 NR1D2 ZNF280C DIDO1 E2F4 PKHD1L1 GTF2I ZSCAN20 ZC2HC1A BRD2 LPP LCOR TP53 | 3.57e-08 | 808 | 234 | 22 | 20412781 | |
| Pubmed | TANC2 RPL29 MAP6 BCLAF1 PSMD2 EWSR1 TRIP11 SYNGAP1 USP31 PTPRS TLN2 BAIAP2 PRRC2A DPYSL2 CAMK2G PCLO MINK1 APC ADGRL1 SPECC1L CASK ZC2HC1A TJP1 SIPA1L1 PDE4DIP EIF4G3 ATP1B1 PCDH1 PCM1 HDLBP | 3.92e-08 | 1431 | 234 | 30 | 37142655 | |
| Pubmed | TANC2 PSD MAST2 FAM53C ABCA7 ZNF469 PTPN14 MTUS1 UBR5 BRPF1 ZBTB21 CIZ1 TAF4 SLAIN2 SFSWAP EP400 WWP1 C16orf96 TEP1 RESF1 BRD2 SIPA1L1 FMN2 LCOR PCM1 TP53 | 4.42e-08 | 1116 | 234 | 26 | 31753913 | |
| Pubmed | TET2 BCLAF1 CDK19 KDM3B PSMD2 INTS3 INTS2 SUPT6H TAF4 NIPBL SLAIN2 GTF2I GTF3C1 | 4.78e-08 | 272 | 234 | 13 | 31010829 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | LEMD3 ADAM9 ITGA6 CDHR5 PTPN14 COBL BAIAP2 RELCH DTNA WWP1 TMEM51 MINK1 CASK CELSR2 FMN2 LYN PCDH1 DCBLD2 | 7.31e-08 | 569 | 234 | 18 | 30639242 |
| Pubmed | CDK19 PSMD2 EWSR1 INTS3 TLK1 UBR5 RECQL5 DCLRE1A PMS2 EP400 SPECC1L GTF2I GTF3C1 MDC1 LCOR SLX4 | 9.04e-08 | 453 | 234 | 16 | 29656893 | |
| Pubmed | 9.13e-08 | 152 | 234 | 10 | 38360978 | ||
| Pubmed | CCP110 HAUS6 INCENP LEMD3 BCLAF1 NEK9 CEP350 RECQL5 CIZ1 PMAIP1 DNAJB1 PMS2 EP400 C2CD3 BRD2 CEP131 CSPP1 LCOR PCM1 | 9.53e-08 | 645 | 234 | 19 | 25281560 | |
| Pubmed | INCENP BCLAF1 KDM3B GFPT1 AURKA UBR5 SUPT6H UFD1 ZBTB21 TAF4 NIPBL DHX16 DNAJB1 DPYSL2 EP400 DIDO1 NCOA5 GTF2I BRD2 GTF3C1 WDHD1 CDK13 MDC1 TP53 | 1.13e-07 | 1014 | 234 | 24 | 32416067 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CCP110 TRIP11 BRAP PTPN14 UBR5 SUPT6H RECQL5 EP400 DTNA APC RIMBP3 RESF1 CEP131 POTEJ SLX4 PCM1 TP53 HDLBP | 1.19e-07 | 588 | 234 | 18 | 38580884 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 KDM3B CC2D1A BCL9 MAST2 ABCA7 TLK1 PTPRS COBL PDZD8 TLN2 EP400 WWP1 ADGRL1 TEP1 DENND1A FBXO46 C2CD3 BRD2 CELSR2 MEGF8 CDK13 CEP131 MAPKBP1 HTT | 1.42e-07 | 1105 | 234 | 25 | 35748872 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | TANC2 RPL29 BCLAF1 RUSC2 AURKA MTUS1 SUPT6H STARD9 MYPN APC TRIOBP SPECC1L CASK NCOA5 | 1.91e-07 | 361 | 234 | 14 | 30344098 |
| Pubmed | PDLIM7 EWSR1 TRIP11 CEP350 LDB1 NYNRIN BAIAP2 PRRC2A DHX16 DTNA WWP1 TEP1 TDRD7 MEGF8 HGS PDE4DIP MAPKBP1 TP53 | 1.95e-07 | 608 | 234 | 18 | 16713569 | |
| Pubmed | UBAP2 BCLAF1 CC2D1A EWSR1 GFPT1 CEP350 STARD9 TAOK1 BAIAP2 PRRC2A DHX16 SFSWAP EP400 DIDO1 SPECC1L SRFBP1 DENND1A FBXO46 GTF2I TJP1 CDK13 CKAP2L CEP131 POTEJ ATP1B1 PCM1 TP53 HDLBP | 1.97e-07 | 1371 | 234 | 28 | 36244648 | |
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 2.01e-07 | 38 | 234 | 6 | 36674791 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL29 LEMD3 BCLAF1 EWSR1 INTS3 AURKA INTS2 SUPT6H RECQL5 CIZ1 DCLRE1A TAF4 NIPBL SFSWAP EP400 BAZ2B GPS2 DIDO1 RFX7 SRFBP1 NCOA5 GTF2I BRD2 GTF3C1 CDK13 MDC1 LCOR | 2.18e-07 | 1294 | 234 | 27 | 30804502 |
| Pubmed | SYNPO2 RPS6KA5 FAM53C CEP350 TLK1 SIMC1 KIAA1328 COBL BAIAP2 CPLANE1 APC ADGRL1 SPECC1L HGS PAK3 HDLBP | 2.33e-07 | 486 | 234 | 16 | 20936779 | |
| Pubmed | GAPVD1 LEMD3 ITGA6 MAST2 CEP350 ZBTB21 TAOK1 RIMBP3C MTCL1 TAF4 PMS2 APC WDHD1 LPP PDE4DIP CKAP2L CEP131 LCOR TP53 | 2.62e-07 | 689 | 234 | 19 | 36543142 | |
| Pubmed | TANC2 CCP110 HAUS6 UTP14A NEK9 CEP350 TLK1 KRBA1 TAOK1 BAZ2B COL27A1 GPRIN3 CC2D1B NCOA5 CDK13 SLX4 | 2.82e-07 | 493 | 234 | 16 | 15368895 | |
| Pubmed | Drastic genetic instability of tumors and normal tissues in Turcot syndrome. | 3.01e-07 | 3 | 234 | 3 | 9419979 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TANC2 CCP110 HAUS6 GAPVD1 UBAP2 PDLIM7 PFKFB2 TRIP11 FAM53C NEK9 TLK1 PTPN14 ZBTB21 CIZ1 BAIAP2 RPGRIP1 DNAJB1 RELCH E2F4 DENND1A PPP2R5D GTF2I SIPA1L1 CEP131 CSPP1 TP53 INVS | 3.27e-07 | 1321 | 234 | 27 | 27173435 |
| Pubmed | HAUS6 GAPVD1 BCLAF1 PSMD2 CC2D1A GFPT1 AURKA PDZD8 PRRC2A DNAJB1 DTNA TMEM51 MINK1 APC CC2D1B PPP2R5D HGS EIF4G3 HDLBP | 3.95e-07 | 708 | 234 | 19 | 39231216 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | KDM3B PSMD2 TLK1 SIMC1 ZBTB21 TAF4 SLAIN2 EP400 GTF2I RESF1 TJP1 LPP SLX4 TP53 HDLBP | 4.05e-07 | 444 | 234 | 15 | 34795231 |
| Pubmed | KCNH8 MYLK RPS6KA5 BCLAF1 ADAM9 INSR KDM3B GFPT1 AURKA TLK1 ADAMTS15 MMP12 PMAIP1 CAMK2G WWP1 APC BRD2 CDK13 LYN | 6.24e-07 | 730 | 234 | 19 | 34857952 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GAPVD1 EMC1 LEMD3 PSMD2 CC2D1A GFPT1 AURKA PTPN14 UBR5 PTPRS UFD1 PRRC2A DNAJB1 DPYSL2 DTNA APOD CASK GTF2I GTF3C1 TJP1 LPP PCM1 | 8.55e-07 | 974 | 234 | 22 | 28675297 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 ACACB BCL9 LDB1 TAF4 NIPBL EP400 GPS2 ZNF521 RFX7 RESF1 MDC1 SLX4 | 8.81e-07 | 351 | 234 | 13 | 38297188 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | INCENP KDM3B BRPF1 RECQL5 ZBTB21 CIZ1 TAF4 NIPBL NPAT DHX16 BAZ2B ZNF280C DIDO1 GTF2I BRD2 GTF3C1 MDC1 | 9.42e-07 | 608 | 234 | 17 | 36089195 |
| Pubmed | EMC1 LEMD3 BCLAF1 UTP14A CC2D1A HSPA12B BRAP USP31 PTPN14 UBR5 SUPT6H CIZ1 PDZD8 BAIAP2 NPAT DNAJB1 DTNA MINK1 TRIOBP CASK PPP2R5D BRD2 HGS CEP131 EIF4G3 CSPP1 PCM1 HDLBP | 9.90e-07 | 1487 | 234 | 28 | 33957083 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ACACB INCENP KDM3B CEP350 UBR5 DCLRE1A DHX16 EP400 DIDO1 GTF2I MDC1 SLX4 HDLBP | 1.06e-06 | 357 | 234 | 13 | 37059091 |
| Pubmed | BCLAF1 CC2D1A TRIP11 PRRC2A NIPBL DHX16 DPYSL2 ZNF280C APC TRIOBP DIDO1 TJP1 LPP | 1.17e-06 | 360 | 234 | 13 | 33111431 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.20e-06 | 4 | 234 | 3 | 19091768 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CCP110 BCLAF1 CDK19 INSR FAM53C CEP350 AURKA BAIAP2 SLAIN2 OCEL1 EP400 APC DIDO1 APOD CASK CDK13 SIPA1L1 TP53 | 1.33e-06 | 695 | 234 | 18 | 23602568 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B EMC1 MAP6 BCLAF1 UTP14A EWSR1 SYNGAP1 SUPT6H NIPBL DHX16 DPYSL2 SFSWAP EP400 APC ZNF521 TRIOBP DIDO1 CASK NCOA5 ZC2HC1A BRD2 GTF3C1 TJP1 | 1.34e-06 | 1082 | 234 | 23 | 38697112 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM5B UBAP2 USP25 KDM3B PSMD2 UBR5 SUPT6H UFD1 PHLPP1 MTCL1 PRRC2A DNAJB1 DTNA CAMK2G APC PAIP1 CASK GTF2I TJP1 SIPA1L1 EIF4G3 TP53 | 1.43e-06 | 1005 | 234 | 22 | 19615732 |
| Pubmed | 1.44e-06 | 118 | 234 | 8 | 30979931 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | HAUS6 UBAP2 PDLIM7 MYPN PHLPP1 APC DIDO1 GTF2I TJP1 PCM1 HDLBP | 1.49e-06 | 256 | 234 | 11 | 33397691 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | EWSR1 RUSC2 SYNGAP1 COBL BAIAP2 CPLANE1 CAMK2G WWP1 TRIOBP ADGRL1 TDRD7 MEGF8 SIPA1L1 HGS MAPKBP1 TP53 | 1.50e-06 | 560 | 234 | 16 | 21653829 |
| Pubmed | MYLK ACACB BCLAF1 UTP14A SKIDA1 PSMD2 CAGE1 TLK1 STARD9 ZBTB21 TAF4 NIPBL CDK5R2 RPGRIP1 PCDHGA7 DTNA CAMK2G PCLO CC2D1B C2orf78 C2CD3 BRD2 GTF3C1 TJP1 CDK13 POTEJ EIF4G3 | 1.75e-06 | 1442 | 234 | 27 | 35575683 | |
| Pubmed | HAUS6 INCENP BCLAF1 UTP14A CEP350 UBR5 MTCL1 NIPBL PPP2R5D PCM1 | 1.79e-06 | 210 | 234 | 10 | 16565220 | |
| Pubmed | TANC2 ACACB KDM3B BCL9 HSPA12B INTS3 TRIP11 GFPT1 CEP350 MTCL1 NIPBL CAMK2G WDHD1 MEGF8 PITPNM3 POTEJ CSPP1 | 1.81e-06 | 638 | 234 | 17 | 31182584 | |
| Pubmed | HAUS6 GAPVD1 LEMD3 PDLIM7 TRIP11 PTPN14 UFD1 APC TJP1 HGS LPP | 1.93e-06 | 263 | 234 | 11 | 34702444 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.97e-06 | 123 | 234 | 8 | 26912792 | |
| Pubmed | GAPVD1 BCLAF1 KDM3B NEK9 TLK1 BAIAP2 DHX16 EP400 GTF2I WDHD1 CDK13 MDC1 CKAP2L FMN2 POTEJ | 2.05e-06 | 506 | 234 | 15 | 30890647 | |
| Pubmed | SUPT6H RECQL5 ZBTB21 DCLRE1A NIPBL EP400 BAZ2B RESF1 BRD2 SLX4 | 2.95e-06 | 222 | 234 | 10 | 37071664 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.98e-06 | 5 | 234 | 3 | 17855024 | |
| Pubmed | LEMD3 PDLIM7 USP25 KDM3B EWSR1 MAST4 LDB1 UBR5 WWP1 CASK CDK13 PDE4DIP PCDH1 TP53 INVS HDLBP | 2.99e-06 | 591 | 234 | 16 | 15231748 | |
| Pubmed | KDM5B LEMD3 TLK1 TAF4 RELCH SFSWAP DIDO1 RFX7 NCOA5 RESF1 KDM7A LCOR | 3.29e-06 | 335 | 234 | 12 | 15741177 | |
| Pubmed | 3.54e-06 | 133 | 234 | 8 | 15144186 | ||
| Pubmed | GAPVD1 UBAP2 BCLAF1 KDM3B EWSR1 PRRC2A DNAJB1 SFSWAP GTF2I BRD2 MDC1 TP53 HDLBP | 3.61e-06 | 399 | 234 | 13 | 35987950 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | BCLAF1 UTP14A EWSR1 DHX16 DNAJB1 EP400 ZNF280C DIDO1 SRFBP1 GTF2I MDC1 | 3.91e-06 | 283 | 234 | 11 | 30585729 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL29 INCENP PDLIM7 BCLAF1 UTP14A PSMD2 EWSR1 AURKA SUPT6H UFD1 PDZD8 DNAJB1 SFSWAP ZNF280C DIDO1 SRFBP1 NCOA5 GTF2I BRD2 GTF3C1 MDC1 | 4.01e-06 | 989 | 234 | 21 | 36424410 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | GAPVD1 MYLK INCENP RPS6KA5 BCLAF1 INSR NEK9 AURKA INTS2 CPLANE1 DTNA CAMK2G MINK1 BRD2 GTF3C1 CDK13 PDE4DIP PAK3 ANKRD36 LYN | 4.13e-06 | 910 | 234 | 20 | 36736316 |
| Pubmed | 4.69e-06 | 98 | 234 | 7 | 34943047 | ||
| Pubmed | 4.71e-06 | 234 | 234 | 10 | 36243803 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 RPS6KA5 SUPT6H TLN2 PRRC2A APC GPRIN3 CASK SIPA1L1 FMN2 INPP5J PCM1 HTT HDLBP | 4.83e-06 | 475 | 234 | 14 | 31040226 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | BCLAF1 EWSR1 AURKA ZBTB21 BAIAP2 DNAJB1 EP400 BAZ2B GPS2 GTF2I BRD2 GTF3C1 TP53 | 4.97e-06 | 411 | 234 | 13 | 35182466 |
| Pubmed | KDM3B PSMD2 MAST2 CHRM1 MEF2A AURKA LDB1 MTUS1 PTPRS PDZD8 CDK5R2 RPGRIP1 PMS2 DTNA APC TDRD7 BRD2 HGS PDE4DIP PITPNM3 PAK3 | 5.20e-06 | 1006 | 234 | 21 | 15226823 | |
| Pubmed | 5.74e-06 | 101 | 234 | 7 | 10997877 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 5.74e-06 | 101 | 234 | 7 | 24613305 | |
| Pubmed | HAUS6 ACACB LEMD3 CEP350 INTS2 MTCL1 PRRC2A APC PAIP1 EIF4G3 | 6.33e-06 | 242 | 234 | 10 | 34011540 | |
| Pubmed | 6.53e-06 | 103 | 234 | 7 | 10819331 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RPL29 GAPVD1 UBAP2 PDLIM7 ITGA6 CC2D1A TRIP11 BAIAP2 DNAJB1 TMEM51 MINK1 TJP1 LPP PCDH1 HDLBP | 7.74e-06 | 565 | 234 | 15 | 25468996 |
| Pubmed | 8.40e-06 | 107 | 234 | 7 | 30995489 | ||
| Interaction | YWHAH interactions | TANC2 TET2 CCP110 KDM5B GAPVD1 UBAP2 EMC1 KDM3B PSMD2 CC2D1A PFKFB2 MAST2 TRIP11 FAM53C RUSC2 SYNGAP1 CEP350 USP31 PTPN14 MAST4 KCNQ5 MTUS1 STARD9 ZBTB21 COBL TAOK1 DCLRE1A MTCL1 BAIAP2 SLAIN2 DNAJB1 SFSWAP CAMK2G MINK1 APC SPECC1L RFX7 DENND1A C2CD3 RESF1 MEGF8 TJP1 SIPA1L1 LPP FMN2 CEP131 EIF4G3 CSPP1 PCM1 HTT | 2.10e-17 | 1102 | 229 | 50 | int:YWHAH |
| Interaction | YWHAG interactions | TANC2 TET2 CCP110 KDM5B GAPVD1 SYNPO2 UBAP2 BCLAF1 KDM3B EWSR1 PFKFB2 MAST2 TRIP11 FAM53C RUSC2 SYNGAP1 CEP350 USP31 PTPN14 MAST4 KCNQ5 MTUS1 STARD9 SIMC1 ZBTB21 COBL TAOK1 MTCL1 BAIAP2 CHMP4C SLAIN2 DNAJB1 CAMK2G MINK1 APC SPECC1L RFX7 DENND1A C2CD3 TJP1 SIPA1L1 FMN2 CEP131 EIF4G3 CSPP1 PCM1 TP53 HTT | 5.84e-14 | 1248 | 229 | 48 | int:YWHAG |
| Interaction | YWHAB interactions | TANC2 TET2 CCP110 KDM5B GAPVD1 EMC1 INSR PFKFB2 MAST2 TRIP11 FAM53C RUSC2 CEP350 USP31 PTPN14 MAST4 KCNQ5 STARD9 ZBTB21 TAOK1 MTCL1 BAIAP2 CHMP4C SLAIN2 CAMK2G MINK1 APC RFX7 DENND1A PPP2R5D TJP1 SIPA1L1 HGS CEP131 PCM1 TP53 HTT | 3.06e-10 | 1014 | 229 | 37 | int:YWHAB |
| Interaction | SFN interactions | TANC2 TET2 CCP110 GAPVD1 INSR MAST2 TRIP11 FAM53C RUSC2 CEP350 USP31 PTPN14 MAST4 KCNQ5 MTUS1 ZBTB21 COBL BAIAP2 CHMP4C DNAJB1 MINK1 APC DENND1A TJP1 SIPA1L1 FMN2 CEP131 TP53 HTT INVS | 3.28e-10 | 692 | 229 | 30 | int:SFN |
| Interaction | TNIK interactions | TANC2 EWSR1 HSPA12B SYNGAP1 PTPRS BAIAP2 DPYSL2 CAMK2G MINK1 APC CASK PPP2R5D TJP1 SIPA1L1 PDE4DIP LYN PCM1 TP53 HTT EPHA5 HDLBP | 2.82e-09 | 381 | 229 | 21 | int:TNIK |
| Interaction | GSK3A interactions | CCP110 RPL29 GAPVD1 ACACB BCLAF1 EWSR1 CEP350 KRBA1 MAST4 MTUS1 UBR5 MYPN COBL MTCL1 DNAJB1 APC RFX7 SIPA1L1 LPP CEP131 LCOR SLX4 PCM1 | 3.65e-09 | 464 | 229 | 23 | int:GSK3A |
| Interaction | CDC14A interactions | CHRM1 BRAP CEP350 MTUS1 KIAA1328 PRRC2A C2CD3 GTF3C1 TJP1 CEP131 CSPP1 TP53 | 5.09e-09 | 111 | 229 | 12 | int:CDC14A |
| Interaction | PCM1 interactions | CCP110 HAUS6 CC2D1A EWSR1 CEP350 AURKA NYNRIN KIAA1328 PHLPP1 BAIAP2 SLAIN2 RPGRIP1 ZNF280C TRIOBP E2F4 DENND1A CASK C2CD3 CKAP2L CEP131 CSPP1 PCM1 | 5.42e-09 | 434 | 229 | 22 | int:PCM1 |
| Interaction | WWTR1 interactions | HAUS6 GAPVD1 UBAP2 PDLIM7 NEK9 BRAP PTPN14 PRRC2A SLAIN2 DNAJB1 EP400 DIDO1 SPECC1L GTF2I GTF3C1 TJP1 LPP PCM1 TP53 HTT HDLBP | 1.69e-08 | 422 | 229 | 21 | int:WWTR1 |
| Interaction | MAPRE1 interactions | TANC2 UTP14A EWSR1 HSPA12B CEP350 AURKA MAST4 MTUS1 UFD1 COBL PRRC2A SLAIN2 CAMK2G APC SPECC1L CASK ZC2HC1A LPP PDE4DIP CKAP2L CEP131 CSPP1 PCM1 | 2.47e-08 | 514 | 229 | 23 | int:MAPRE1 |
| Interaction | YWHAZ interactions | TANC2 TET2 CCP110 KDM5B GAPVD1 SYNPO2 RPS6KA5 MAP6 EWSR1 PFKFB2 MAST2 FAM53C RUSC2 SYNGAP1 USP31 PTPN14 MAST4 LDB1 KCNQ5 MTUS1 STARD9 SIMC1 ZBTB21 BAIAP2 PRRC2A CHMP4C DPYSL2 CAMK2G MINK1 APC DENND1A TJP1 SIPA1L1 MDC1 CEP131 PCM1 TP53 HTT INVS | 3.46e-08 | 1319 | 229 | 39 | int:YWHAZ |
| Interaction | NUP43 interactions | ACACB INCENP BCLAF1 UBR5 SUPT6H RECQL5 CIZ1 TAF4 BAIAP2 NIPBL NR1D2 NPAT EP400 BAZ2B ZNF280C APC E2F4 TDRD7 GTF2I RESF1 MDC1 EIF4G3 LCOR SLX4 TP53 | 5.28e-08 | 625 | 229 | 25 | int:NUP43 |
| Interaction | MAPRE3 interactions | CCP110 CEP350 AURKA MAST4 MTUS1 COBL PRRC2A SLAIN2 MINK1 APC SPECC1L ZC2HC1A PDE4DIP CKAP2L CEP131 | 6.35e-08 | 230 | 229 | 15 | int:MAPRE3 |
| Interaction | TERF2IP interactions | INCENP UTP14A KDM3B SUPT6H RECQL5 ZBTB21 CIZ1 TAF4 NIPBL NPAT DHX16 SFSWAP EP400 ZNF280C DIDO1 E2F4 GTF2I GTF3C1 WDHD1 TJP1 CDK13 MDC1 SLX4 | 9.02e-08 | 552 | 229 | 23 | int:TERF2IP |
| Interaction | TRIM36 interactions | CCP110 CC2D1A CEP350 USP31 MAST4 MTUS1 MTCL1 SLAIN2 APC SPECC1L ZC2HC1A CKAP2L | 9.62e-08 | 144 | 229 | 12 | int:TRIM36 |
| Interaction | GSK3B interactions | CCP110 GAPVD1 ACACB PSMD2 EWSR1 GFPT1 SYNGAP1 CEP350 AURKA KRBA1 MAST4 MTUS1 UBR5 MYPN PHLPP1 COBL MTCL1 PMAIP1 DPYSL2 APC TRIOBP PPP2R5D TJP1 SIPA1L1 LPP CEP131 SLX4 PCM1 TP53 | 2.04e-07 | 868 | 229 | 29 | int:GSK3B |
| Interaction | NINL interactions | CCP110 HAUS6 PDLIM7 UTP14A CC2D1A EWSR1 CEP350 MAST4 MTUS1 UBR5 COBL CAMK2G GPS2 SIPA1L1 LPP CEP131 CSPP1 PCM1 TP53 HTT | 3.11e-07 | 458 | 229 | 20 | int:NINL |
| Interaction | CEP128 interactions | CCP110 HAUS6 PDLIM7 CC2D1A CEP350 AURKA SLAIN2 APC CASK C2CD3 TJP1 SIPA1L1 CEP131 CSPP1 PCM1 TP53 | 3.16e-07 | 297 | 229 | 16 | int:CEP128 |
| Interaction | YWHAQ interactions | TANC2 TET2 CCP110 KDM5B UBAP2 PFKFB2 MAST2 TRIP11 FAM53C RUSC2 CEP350 USP31 PTPN14 MAST4 KCNQ5 MTUS1 STARD9 ZBTB21 TAOK1 BAIAP2 CHMP4C WWP1 MINK1 APC SPECC1L RFX7 DENND1A WDHD1 TJP1 SIPA1L1 CEP131 PCM1 HTT | 4.70e-07 | 1118 | 229 | 33 | int:YWHAQ |
| Interaction | CAMSAP2 interactions | CCP110 SYNGAP1 CEP350 MTUS1 ZBTB21 SLAIN2 DENND1A TDRD7 SIPA1L1 CKAP2L CEP131 PCM1 | 5.50e-07 | 169 | 229 | 12 | int:CAMSAP2 |
| Interaction | CEP135 interactions | CCP110 HAUS6 CC2D1A RUSC2 CEP350 KIAA1328 APC NCOA5 C2CD3 TJP1 SIPA1L1 CEP131 CSPP1 PCM1 TP53 | 5.55e-07 | 272 | 229 | 15 | int:CEP135 |
| Interaction | EPHA2 interactions | ACACB EPHA6 LEMD3 INSR ITGA6 HSPA12B TRIP11 USP31 AURKA PTPN14 GORAB PHLPP1 COBL DTNA TMEM51 MINK1 TRIOBP ADGRL1 GPRIN3 CASK CELSR2 HGS LYN TP53 EPHA5 | 7.33e-07 | 719 | 229 | 25 | int:EPHA2 |
| Interaction | NAA40 interactions | RPL29 HAUS6 GAPVD1 UBAP2 ACACB BCLAF1 UTP14A KDM3B CC2D1A TRIP11 NEK9 GFPT1 BRAP ZBTB21 CIZ1 PRRC2A NIPBL DHX16 DNAJB1 DPYSL2 EP400 ZNF280C DIDO1 GTF2I TJP1 LPP EIF4G3 PCM1 TP53 HDLBP | 7.51e-07 | 978 | 229 | 30 | int:NAA40 |
| Interaction | YWHAE interactions | TANC2 TET2 KDM5B GAPVD1 PDLIM7 EWSR1 PFKFB2 MAST2 TRIP11 FAM53C RUSC2 SYNGAP1 USP31 TLK1 PTPN14 MAST4 KCNQ5 ZBTB21 TAF4 BAIAP2 PRRC2A CHMP4C CAMK2G MINK1 APC DENND1A CASK CDK13 SIPA1L1 CEP131 LCOR PCM1 TP53 HTT HDLBP | 7.78e-07 | 1256 | 229 | 35 | int:YWHAE |
| Interaction | CEP104 interactions | 7.80e-07 | 89 | 229 | 9 | int:CEP104 | |
| Interaction | NIN interactions | HAUS6 UTP14A CC2D1A GFPT1 CEP350 AURKA BAIAP2 CPLANE1 DPYSL2 APC C2CD3 TJP1 SIPA1L1 CEP131 CSPP1 PCM1 TP53 | 8.19e-07 | 359 | 229 | 17 | int:NIN |
| Interaction | NUCKS1 interactions | KDM5B KDM3B EWSR1 INTS3 BRPF1 PHLPP1 CHMP4C ZNF280C DIDO1 CC2D1B MDC1 LCOR HTT | 1.49e-06 | 220 | 229 | 13 | int:NUCKS1 |
| Interaction | MIB1 interactions | CCP110 HAUS6 PTPN22 BRAP AURKA UFD1 PDZD8 GPRIN3 E2F4 TJP1 HGS CEP131 CSPP1 PCM1 TP53 | 1.54e-06 | 295 | 229 | 15 | int:MIB1 |
| Interaction | CEBPA interactions | TET2 SP4 BCLAF1 KDM3B CC2D1A PTPN22 EWSR1 BCL9 MEF2A AURKA TLK1 UBR5 ZBTB21 TAF4 PRRC2A NIPBL SLAIN2 RPGRIP1 DNAJB1 EP400 BAZ2B CAMK2G GPS2 DIDO1 E2F4 NCOA5 GTF2I RESF1 GTF3C1 CDK13 LCOR PCM1 TP53 HDLBP | 1.79e-06 | 1245 | 229 | 34 | int:CEBPA |
| Interaction | SLX4 interactions | ACACB INCENP KDM3B CEP350 UBR5 SUPT6H RECQL5 ZBTB21 DCLRE1A NIPBL DHX16 EP400 BAZ2B DIDO1 GTF2I RESF1 BRD2 MDC1 SLX4 TP53 HDLBP | 2.56e-06 | 572 | 229 | 21 | int:SLX4 |
| Interaction | LATS1 interactions | TET2 CCP110 MAST2 TRIP11 CEP350 PTPN14 TAOK1 TAF4 SLAIN2 WWP1 MINK1 APC XIRP2 TJP1 SIPA1L1 CEP131 PCM1 TP53 | 3.11e-06 | 440 | 229 | 18 | int:LATS1 |
| Interaction | KDM1A interactions | TET2 KDM5B HAUS6 GAPVD1 ACACB CAGE1 NEK9 CEP350 INTS2 UBR5 ZBTB21 BAIAP2 PHF21B NPAT CCDC121 EP400 CAMK2G ZNF280C APC E2F4 GTF2I RESF1 GTF3C1 PDE4DIP CEP131 PCM1 TP53 HTT | 3.26e-06 | 941 | 229 | 28 | int:KDM1A |
| Interaction | SYNE3 interactions | TANC2 CCP110 EMC1 LEMD3 PDLIM7 CC2D1A CEP350 PTPN14 KCNQ5 PDZD8 APC C2CD3 SIPA1L1 HGS LPP CEP131 CSPP1 TP53 | 3.53e-06 | 444 | 229 | 18 | int:SYNE3 |
| Interaction | TPX2 interactions | LEMD3 EWSR1 AURKA PHLPP1 PRRC2A SFSWAP DIDO1 E2F4 NCOA5 MDC1 SLX4 HDLBP | 3.98e-06 | 204 | 229 | 12 | int:TPX2 |
| Interaction | MED4 interactions | CCP110 HAUS6 BCLAF1 CDK19 PTPN22 EWSR1 TRIP11 NEK9 CEP350 UBR5 RECQL5 PMAIP1 DNAJB1 C2CD3 HGS CEP131 CSPP1 PCM1 | 4.25e-06 | 450 | 229 | 18 | int:MED4 |
| Interaction | SUPT5H interactions | EMC1 BCLAF1 INTS3 INTS2 UBR5 SUPT6H RECQL5 NIPBL NPAT EP400 GPS2 NCOA5 CCDC71 GTF3C1 SLX4 PCM1 TP53 | 4.62e-06 | 408 | 229 | 17 | int:SUPT5H |
| Interaction | CDKL5 interactions | 5.79e-06 | 113 | 229 | 9 | int:CDKL5 | |
| Interaction | ZYX interactions | TANC2 CCP110 PDLIM7 CEP350 PTPN14 COBL TLN2 APC PLEKHG4B TJP1 SIPA1L1 HGS LPP TP53 HDLBP | 5.84e-06 | 329 | 229 | 15 | int:ZYX |
| Interaction | SEC23A interactions | EPHA6 INSR EWSR1 GFPT1 CHMP4C DTNA ZC2HC1A HGS SLX4 TP53 HTT EPHA5 HDLBP | 7.54e-06 | 255 | 229 | 13 | int:SEC23A |
| Interaction | RNF43 interactions | KDM5B HAUS6 GAPVD1 LEMD3 PDLIM7 PSMD2 TRIP11 PTPN14 UBR5 UFD1 DNAJB1 APC PAIP1 TJP1 HGS LPP TP53 | 8.41e-06 | 427 | 229 | 17 | int:RNF43 |
| Interaction | NUP50 interactions | UBAP2 LEMD3 UTP14A KDM3B SUPT6H PDZD8 TAF4 NPAT DHX16 SFSWAP SRFBP1 PAIP1 WDHD1 LCOR SLX4 | 8.96e-06 | 341 | 229 | 15 | int:NUP50 |
| Interaction | SMC5 interactions | UBAP2 INCENP LEMD3 BCLAF1 UTP14A EWSR1 RECQL5 SIMC1 CIZ1 TAF4 PRRC2A NIPBL NPAT SFSWAP EP400 BAZ2B ZNF280C DIDO1 SRFBP1 GTF2I BRD2 TJP1 MDC1 LCOR SLX4 PCM1 TP53 HDLBP | 1.02e-05 | 1000 | 229 | 28 | int:SMC5 |
| Interaction | TP53BP1 interactions | UBAP2 RPS6KA5 CDK19 PSMD2 EWSR1 INTS3 MEF2A SYNGAP1 TLK1 UBR5 RECQL5 DCLRE1A EP400 E2F4 GTF3C1 MDC1 HGS SLX4 TP53 | 1.19e-05 | 533 | 229 | 19 | int:TP53BP1 |
| Interaction | SPICE1 interactions | HAUS6 CC2D1A CEP350 MTUS1 C2CD3 ZC2HC1A CKAP2L CEP131 CSPP1 PCM1 TP53 | 1.23e-05 | 191 | 229 | 11 | int:SPICE1 |
| Interaction | SNRNP40 interactions | ACACB BCLAF1 EWSR1 BCL9 TLK1 UBR5 SUPT6H RECQL5 ZBTB21 CIZ1 PDZD8 TAF4 NPAT DHX16 SFSWAP EP400 BAZ2B ZNF280C NCOA5 MDC1 HDLBP | 1.33e-05 | 637 | 229 | 21 | int:SNRNP40 |
| Interaction | CNTRL interactions | HAUS6 CC2D1A CEP350 AURKA SLAIN2 C2CD3 TJP1 CEP131 CSPP1 PCM1 TP53 | 1.36e-05 | 193 | 229 | 11 | int:CNTRL |
| Interaction | CNOT9 interactions | CCP110 HAUS6 UBAP2 CEP350 AURKA PRRC2A MINK1 APC PAIP1 CEP131 CSPP1 PCM1 | 1.41e-05 | 231 | 229 | 12 | int:CNOT9 |
| Interaction | SASS6 interactions | CCP110 HAUS6 TRIP11 CEP350 APC TJP1 SIPA1L1 CEP131 CSPP1 PCM1 | 1.44e-05 | 159 | 229 | 10 | int:SASS6 |
| Interaction | H2BC9 interactions | CC2D1A CEP350 ZNF469 TAF4 PRRC2A CDK5R2 BAZ2B PCLO CC2D1B DOK2 SPECC1L TEP1 XIRP2 FGFBP2 MDC1 PDE4DIP ANKRD36 | 1.48e-05 | 446 | 229 | 17 | int:H2BC9 |
| Interaction | VIM interactions | TET2 CCP110 RPL29 PDLIM7 UTP14A CC2D1A PTPN22 BRAP SH3YL1 SYNGAP1 UBR5 TAOK1 SLAIN2 TRIOBP RESF1 TJP1 HGS LPP CEP131 SLX4 TP53 HTT INVS HDLBP | 1.64e-05 | 804 | 229 | 24 | int:VIM |
| Interaction | MAST3 interactions | TANC2 MAST2 FAM53C PTPN14 MAST4 ZBTB21 DENND1A SIPA1L1 HDLBP | 1.70e-05 | 129 | 229 | 9 | int:MAST3 |
| Interaction | EZR interactions | HAUS6 MYLK AURKA PTPN14 COBL PDZD8 PMAIP1 SLAIN2 DTNA WWP1 MINK1 APC TRIOBP CASK TJP1 HGS LPP EIF4G3 TP53 | 1.98e-05 | 553 | 229 | 19 | int:EZR |
| Interaction | DENND1A interactions | 2.01e-05 | 101 | 229 | 8 | int:DENND1A | |
| Interaction | TRIM52 interactions | 2.17e-05 | 133 | 229 | 9 | int:TRIM52 | |
| Interaction | MAPKAPK2 interactions | PDLIM7 UTP14A PRRC2A CHMP4C DNAJB1 SFSWAP CAMK2G DIDO1 CEP131 | 2.30e-05 | 134 | 229 | 9 | int:MAPKAPK2 |
| Interaction | PLK1 interactions | GAPVD1 FAM53C PTHLH AURKA KRBA1 PTPN14 UBR5 RECQL5 SIMC1 PHLPP1 RELCH APC TRIOBP PPP2R5D GTF3C1 SLX4 PCM1 TP53 | 2.31e-05 | 510 | 229 | 18 | int:PLK1 |
| Interaction | SUMO1 interactions | USP25 PSMD2 EWSR1 MEF2A SIMC1 PHLPP1 PRRC2A DHX16 TJP1 HGS SLX4 TP53 HTT | 2.64e-05 | 287 | 229 | 13 | int:SUMO1 |
| Interaction | LATS2 interactions | TANC2 CCP110 AURKA PTPN14 UBR5 DNAJB1 APC TJP1 SIPA1L1 CEP131 CSPP1 PCM1 TP53 | 2.84e-05 | 289 | 229 | 13 | int:LATS2 |
| Interaction | CEP120 interactions | 2.85e-05 | 106 | 229 | 8 | int:CEP120 | |
| Interaction | DYRK2 interactions | 2.98e-05 | 173 | 229 | 10 | int:DYRK2 | |
| Interaction | BAG2 interactions | GAPVD1 UBAP2 KDM3B SUPT6H CIZ1 PHLPP1 CHMP4C DNAJB1 DPYSL2 E2F4 TEP1 PPP2R5D BRD2 WDHD1 MDC1 HGS EIF4G3 TP53 HTT HDLBP | 3.06e-05 | 622 | 229 | 20 | int:BAG2 |
| Interaction | SIPA1L1 interactions | TANC2 FAM53C SYNGAP1 PTPN14 ZBTB21 E2F4 DENND1A TJP1 SIPA1L1 HTT | 3.13e-05 | 174 | 229 | 10 | int:SIPA1L1 |
| Interaction | BICD2 interactions | PDLIM7 UTP14A CC2D1A MAST2 NEK9 PTPN14 MAST4 BAIAP2 SLAIN2 DPYSL2 PAIP1 C2CD3 PPP2R5D ZC2HC1A TJP1 PCM1 | 3.16e-05 | 426 | 229 | 16 | int:BICD2 |
| Interaction | PNMA2 interactions | CCP110 CEP350 AURKA KRBA1 UBR5 RIMBP3C MTCL1 PRRC2A CAMK2G GTF3C1 CEP131 SLX4 | 3.20e-05 | 251 | 229 | 12 | int:PNMA2 |
| Interaction | RHOB interactions | RPL29 ADAM9 INSR ITGA6 CC2D1A USP31 AURKA PTPN14 PTPRS COBL BAIAP2 DTNA MINK1 TRIOBP ADGRL1 GPRIN3 CASK TJP1 SIPA1L1 HGS FMN2 ATP1B1 LYN EPHA5 | 3.31e-05 | 840 | 229 | 24 | int:RHOB |
| Interaction | INCENP interactions | 3.51e-05 | 80 | 229 | 7 | int:INCENP | |
| Interaction | USP7 interactions | TET2 CCP110 SP4 UBAP2 ACACB MYO7B BCLAF1 SKIDA1 PSMD2 EWSR1 MAST2 HOXA3 AURKA NYNRIN BRPF1 MYPN VWA3B MINK1 ZNF280C APC ZNF521 ADGRL1 C16orf96 E2F4 APOD GTF2I MDC1 PITPNM3 KIAA1755 LCOR IL6R TP53 | 3.67e-05 | 1313 | 229 | 32 | int:USP7 |
| Interaction | DDX23 interactions | BCLAF1 UTP14A EWSR1 UBR5 SUPT6H BRPF1 RECQL5 DHX16 CHMP4C SFSWAP SRFBP1 BRD2 WDHD1 CDK13 LYN PCM1 HDLBP | 3.75e-05 | 480 | 229 | 17 | int:DDX23 |
| Interaction | SEPTIN10 interactions | 4.07e-05 | 144 | 229 | 9 | int:SEPTIN10 | |
| Interaction | PPP2CA interactions | UBAP2 INTS3 CEP350 AURKA INTS2 CHMP4C PMS2 EP400 CAMK2G APC PPP2R5D MDC1 LPP CEP131 PCM1 TP53 HTT | 4.15e-05 | 484 | 229 | 17 | int:PPP2CA |
| Interaction | SIRT7 interactions | GAPVD1 INCENP UTP14A PSMD2 EWSR1 GFPT1 AURKA UBR5 SUPT6H PRRC2A NIPBL DHX16 DPYSL2 DIDO1 GTF2I GTF3C1 TJP1 MDC1 EIF4G3 PCM1 TP53 HDLBP | 4.31e-05 | 744 | 229 | 22 | int:SIRT7 |
| Interaction | FMR1 interactions | UBAP2 BCLAF1 EWSR1 BCL9 SYNGAP1 LDB1 MTCL1 PRRC2A NIPBL DPYSL2 CAMK2G APC E2F4 CASK ZC2HC1A TJP1 PCM1 HDLBP | 4.42e-05 | 536 | 229 | 18 | int:FMR1 |
| Interaction | ARL16 interactions | 4.45e-05 | 83 | 229 | 7 | int:ARL16 | |
| Interaction | ZNF451 interactions | 4.45e-05 | 83 | 229 | 7 | int:ZNF451 | |
| Interaction | CEP89 interactions | 4.78e-05 | 147 | 229 | 9 | int:CEP89 | |
| Interaction | GOLGA1 interactions | CCP110 GAPVD1 CEP350 MTUS1 KIAA1328 SLAIN2 APC CEP131 CSPP1 PCM1 | 4.81e-05 | 183 | 229 | 10 | int:GOLGA1 |
| Interaction | H2BC21 interactions | KDM5B INCENP RPS6KA5 BCLAF1 INTS3 SUPT6H BRPF1 PRRC2A NIPBL CDK5R2 EP400 PCLO ZNF280C DIDO1 CC2D1B C2CD3 CCDC71 BRD2 MDC1 LCOR TP53 | 4.86e-05 | 696 | 229 | 21 | int:H2BC21 |
| Interaction | CBX3 interactions | INCENP LEMD3 UTP14A AURKA ZBTB21 TAF4 NIPBL DHX16 CHMP4C EP400 ZNF280C SRFBP1 GTF2I CCDC71 BRD2 GTF3C1 MDC1 LCOR SLX4 HDLBP | 5.19e-05 | 646 | 229 | 20 | int:CBX3 |
| Interaction | CAPN13 interactions | 5.50e-05 | 19 | 229 | 4 | int:CAPN13 | |
| Interaction | RPGRIP1L interactions | CCP110 HAUS6 CEP350 CPLANE1 APC TJP1 SIPA1L1 CEP131 CSPP1 PCM1 TP53 | 5.59e-05 | 225 | 229 | 11 | int:RPGRIP1L |
| Interaction | TOP3B interactions | TANC2 UBAP2 KDM3B CC2D1A BCL9 MAST2 ABCA7 TLK1 PTPRS RECQL5 COBL PDZD8 TLN2 PRRC2A EP400 WWP1 ADGRL1 TEP1 DENND1A FBXO46 PAIP1 C2CD3 GTF2I BRD2 CELSR2 MEGF8 CDK13 MDC1 CEP131 MAPKBP1 LYN TP53 HTT HDLBP | 5.84e-05 | 1470 | 229 | 34 | int:TOP3B |
| Interaction | KCNA3 interactions | HAUS6 GAPVD1 BCLAF1 PSMD2 CC2D1A GFPT1 AURKA COBL PDZD8 TLN2 PRRC2A DNAJB1 DTNA COL27A1 TMEM51 MINK1 APC CC2D1B SPECC1L PPP2R5D SIPA1L1 HGS EIF4G3 HDLBP | 5.86e-05 | 871 | 229 | 24 | int:KCNA3 |
| Interaction | CSNK1E interactions | GAPVD1 TAOK1 BAIAP2 NR1D2 DHX16 APC PPP2R5D GTF3C1 PDE4DIP CEP131 SLX4 PCM1 TP53 | 6.04e-05 | 311 | 229 | 13 | int:CSNK1E |
| Interaction | C11orf52 interactions | INSR ITGA6 USP31 PTPN14 BAIAP2 DTNA TMEM51 MINK1 GPRIN3 CASK HGS FMN2 LYN | 6.04e-05 | 311 | 229 | 13 | int:C11orf52 |
| Interaction | OCLN interactions | ADAM9 INSR CC2D1A TRIP11 USP31 PTPN14 DTNA TMEM51 MINK1 APC GPRIN3 CASK TJP1 SIPA1L1 HGS FMN2 LYN | 6.21e-05 | 500 | 229 | 17 | int:OCLN |
| Interaction | NDC80 interactions | CCP110 HAUS6 CAGE1 CEP350 AURKA KIAA1328 MTCL1 C2CD3 GTF2I HGS CEP131 CSPP1 PCM1 | 6.24e-05 | 312 | 229 | 13 | int:NDC80 |
| Interaction | AMOT interactions | CCP110 EWSR1 NEK9 CEP350 PTPN14 KIAA1328 MTCL1 WWP1 APC TJP1 SIPA1L1 CEP131 CSPP1 | 6.24e-05 | 312 | 229 | 13 | int:AMOT |
| Interaction | HMGN5 interactions | 6.86e-05 | 154 | 229 | 9 | int:HMGN5 | |
| Interaction | TMSB4Y interactions | 7.62e-05 | 39 | 229 | 5 | int:TMSB4Y | |
| Interaction | SAMD4B interactions | 7.79e-05 | 122 | 229 | 8 | int:SAMD4B | |
| Interaction | DYNLL1 interactions | RPS6KA5 MAST2 NEK9 AURKA TLK1 KCNQ5 CIZ1 MTCL1 RELCH CAMK2G MINK1 PDE4DIP CEP131 PCM1 TP53 HTT HDLBP | 7.91e-05 | 510 | 229 | 17 | int:DYNLL1 |
| Interaction | KIAA0753 interactions | 7.96e-05 | 157 | 229 | 9 | int:KIAA0753 | |
| Interaction | ODF2 interactions | 8.36e-05 | 158 | 229 | 9 | int:ODF2 | |
| Interaction | CTDSPL interactions | 8.62e-05 | 92 | 229 | 7 | int:CTDSPL | |
| Interaction | EZH1 interactions | 8.62e-05 | 92 | 229 | 7 | int:EZH1 | |
| Interaction | BARD1 interactions | BCLAF1 USP25 EWSR1 AURKA UBR5 PDZD8 E2F4 GTF3C1 CDK13 MDC1 ATP1B1 SLX4 TP53 | 8.85e-05 | 323 | 229 | 13 | int:BARD1 |
| Interaction | MAP4 interactions | CCP110 PSMD2 SYNGAP1 PHLPP1 PDZD8 DPYSL2 E2F4 WDHD1 CKAP2L CEP131 MAPKBP1 TP53 INVS | 9.13e-05 | 324 | 229 | 13 | int:MAP4 |
| Interaction | SQSTM1 interactions | HAUS6 GAPVD1 SYNPO2 PDLIM7 INSR PSMD2 CC2D1A CEP350 AURKA NYNRIN SIMC1 PHLPP1 TAOK1 MTCL1 HEATR5B PRRC2A NIPBL PMAIP1 SLAIN2 MINK1 PAIP1 PPP2R5D TJP1 HGS LPP CEP131 CSPP1 TP53 HTT HDLBP | 9.58e-05 | 1257 | 229 | 30 | int:SQSTM1 |
| Interaction | ZBTB21 interactions | 9.66e-05 | 161 | 229 | 9 | int:ZBTB21 | |
| Interaction | AP2B1 interactions | CCP110 PSMD2 TRIP11 CEP350 HEATR5B SLAIN2 APC E2F4 DENND1A GTF2I CEP131 SLX4 TP53 HTT | 9.99e-05 | 373 | 229 | 14 | int:AP2B1 |
| GeneFamily | PDZ domain containing | 3.79e-06 | 152 | 145 | 9 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.55e-06 | 36 | 145 | 5 | 823 | |
| GeneFamily | PHD finger proteins | 8.59e-05 | 90 | 145 | 6 | 88 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 9.04e-04 | 24 | 145 | 3 | 485 | |
| GeneFamily | Fibronectin type III domain containing | 1.85e-03 | 160 | 145 | 6 | 555 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM5B GAPVD1 CDK19 KDM3B ITGA6 MAST2 MEF2A CEP350 AURKA TLK1 UBR5 PHLPP1 MTCL1 TAF4 NIPBL NPAT BAZ2B WWP1 APC SPECC1L PAIP1 CASK TDRD7 C2CD3 WDHD1 CDK13 SIPA1L1 EIF4G3 LYN | 7.50e-10 | 856 | 233 | 29 | M4500 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TANC2 KDM5B HAUS6 RPS6KA5 CDK19 INSR FAM53C MEF2A PTHLH GFPT1 BRAP MTUS1 NIPBL PMAIP1 NR1D2 DNAJB1 SFSWAP BAZ2B RCAN3 RESF1 ZC2HC1A BRD2 TJP1 PDE4DIP LCOR IL6R | 2.44e-08 | 822 | 233 | 26 | M6782 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | GAPVD1 CEP350 AURKA TLK1 MAST4 MTUS1 UBR5 PHLPP1 MTCL1 NPAT BAZ2B DIDO1 WDHD1 MDC1 LPP | 8.93e-08 | 300 | 233 | 15 | M8702 |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | TANC2 GPR155 TET2 CEP350 FNIP2 RELCH BAZ2B RESF1 BRD2 FGFBP2 KDM7A LCOR | 1.85e-07 | 194 | 233 | 12 | M7306 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | TET2 UBAP2 MAST2 CEP350 TAOK1 VWA3B RFX7 GTF3C1 CELSR2 SIPA1L1 PCM1 | 6.83e-07 | 180 | 233 | 11 | M8239 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 EMC1 BCLAF1 KDM3B PSMD2 BCL9 TLK1 PDZD8 TAOK1 DPYSL2 BAZ2B TRIOBP RFX7 HGS LPP ATP1B1 TP53 | 1.10e-06 | 467 | 233 | 17 | M1347 |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | TANC2 EWSR1 SYNGAP1 KRBA1 BRPF1 CIZ1 PHF21B BAZ2B MINK1 CC2D1B | 1.28e-06 | 154 | 233 | 10 | M6824 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TANC2 MAP6 PFKFB2 BCL9 TRIP11 GFPT1 MAST4 PDZD8 TAOK1 NR1D2 FNIP2 SLAIN2 DNAJB1 DPYSL2 PCLO APC SPECC1L RCAN3 GTF3C1 PDE4DIP FMN2 KDM7A EIF4G3 IL6R PCM1 | 1.30e-06 | 946 | 233 | 25 | M39169 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 EMC1 BCLAF1 KDM3B PSMD2 BCL9 TLK1 PDZD8 TAOK1 DPYSL2 BAZ2B TRIOBP RFX7 HGS LPP ATP1B1 TP53 | 1.79e-06 | 484 | 233 | 17 | MM999 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HAUS6 BCLAF1 ADAM9 USP25 ITGA6 TRIP11 CEP350 MTUS1 CPLANE1 NIPBL BAZ2B WWP1 APC PAIP1 TDRD7 RESF1 WDHD1 ATP1B1 CSPP1 PCM1 | 1.92e-06 | 656 | 233 | 20 | M18979 |
| Coexpression | GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP | GAPVD1 EMC1 EVI2B PTPN22 PDZD8 PHF21B OCEL1 C16orf96 DENND1A PAIP1 LYN | 1.92e-06 | 200 | 233 | 11 | M8468 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | GAPVD1 CEP350 TLK1 UBR5 PHLPP1 MTCL1 TAF4 BAZ2B SPECC1L PAIP1 CASK TDRD7 C2CD3 CDK13 EIF4G3 LYN | 4.83e-06 | 466 | 233 | 16 | M13522 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.20e-05 | 157 | 233 | 9 | M7733 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP | GPR155 CDK19 STARD9 DHX16 DPYSL2 CAMK2G TEP1 GTF3C1 EIF4G3 IL6R | 1.31e-05 | 200 | 233 | 10 | M8653 |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP | GAPVD1 HOXA3 STARD9 CPLANE1 FNIP2 OCEL1 WWP1 TRIOBP CC2D1B CEP131 | 1.31e-05 | 200 | 233 | 10 | M6668 |
| Coexpression | GSE3982_DC_VS_MAC_LPS_STIM_UP | 1.31e-05 | 200 | 233 | 10 | M5387 | |
| Coexpression | KIM_WT1_TARGETS_12HR_UP | 1.88e-05 | 166 | 233 | 9 | M15535 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 2.64e-05 | 217 | 233 | 10 | M16407 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 4.02e-05 | 228 | 233 | 10 | MM1014 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN | 4.63e-05 | 106 | 233 | 7 | M9160 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 7.73e-05 | 199 | 233 | 9 | M9255 | |
| Coexpression | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY | 7.80e-05 | 26 | 233 | 4 | M16488 | |
| Coexpression | MCCABE_HOXC6_TARGETS_UP | 7.95e-05 | 10 | 233 | 3 | M16591 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 8.04e-05 | 200 | 233 | 9 | M9449 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 8.04e-05 | 200 | 233 | 9 | M5980 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 8.04e-05 | 200 | 233 | 9 | M8032 | |
| Coexpression | GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN | 8.04e-05 | 200 | 233 | 9 | M3491 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 8.04e-05 | 200 | 233 | 9 | M8997 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL | 1.13e-04 | 122 | 233 | 7 | M45802 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | SP4 UBAP2 INCENP LEMD3 TBL1Y BCLAF1 CAGE1 MEF2A SLC13A4 UFD1 SFSWAP GPS2 IGDCC3 LPP HDLBP | 1.15e-04 | 543 | 233 | 15 | MM997 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 GPR155 SP4 KCNH8 PSD MAP6 RUSC2 MAST4 MTUS1 TLN2 PCLO APC ADGRL1 GPRIN3 IRX1 RFX7 CASK PDE4DIP PAK3 ANKRD36 ATP1B1 PCDH1 ICA1L | 1.47e-04 | 1106 | 233 | 23 | M39071 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.60e-04 | 219 | 233 | 9 | M41199 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | KCNH8 MAP6 ITGA6 NYAP1 PHF21B FNIP2 ZNF521 GPRIN3 PAK3 FMN2 LCOR | 1.84e-04 | 328 | 233 | 11 | M39064 |
| Coexpression | GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP | 2.02e-04 | 178 | 233 | 8 | M8591 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNPROG | 2.23e-04 | 229 | 233 | 9 | M39062 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SP4 ADAM9 KDM3B PSMD2 PTPN22 EWSR1 PFKFB2 TRIP11 NEK9 MEF2A CEP350 UBR5 CIZ1 TAF4 NIPBL DPYSL2 SFSWAP APC PAIP1 PPP2R5D CDK13 PDE4DIP IL6R PCM1 | 2.27e-04 | 1215 | 233 | 24 | M41122 |
| Coexpression | BENPORATH_CYCLING_GENES | KDM5B BCLAF1 INSR ABCA7 AURKA MTCL1 BAIAP2 CPLANE1 NIPBL NPAT DNAJB1 ZNF521 NCOA5 TTC31 MDC1 LPP | 2.45e-04 | 648 | 233 | 16 | M8156 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | SP4 UBAP2 INCENP LEMD3 BCLAF1 CAGE1 MEF2A SLC13A4 UFD1 SFSWAP GPS2 IGDCC3 LPP HDLBP | 2.47e-04 | 519 | 233 | 14 | M3395 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | EMC1 BCLAF1 BCL9 ABCA7 RUSC2 MAST4 PTPRS BAIAP2 SFSWAP DIDO1 THBS3 PCDH1 HTT | 2.47e-04 | 457 | 233 | 13 | M1613 |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP | 2.65e-04 | 140 | 233 | 7 | M2435 | |
| Coexpression | BROWNE_HCMV_INFECTION_12HR_DN | 2.75e-04 | 100 | 233 | 6 | M5775 | |
| Coexpression | SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP | 2.92e-04 | 15 | 233 | 3 | M9251 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_4_DN | 2.92e-04 | 15 | 233 | 3 | M2171 | |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN | 3.14e-04 | 190 | 233 | 8 | M9428 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | EMC1 BCLAF1 BCL9 ABCA7 RUSC2 MAST4 PTPRS BAIAP2 SFSWAP DIDO1 THBS3 PCDH1 HTT | 3.23e-04 | 470 | 233 | 13 | MM1053 |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | HAUS6 GAPVD1 RPS6KA5 LEMD3 TBL1Y BCLAF1 ITGA6 NEK9 HOXA3 AURKA TLK1 PHLPP1 PDZD8 OCEL1 DIDO1 WDHD1 FGFBP3 MDC1 CKAP2L CEP131 RIMBP3B | 3.42e-04 | 1023 | 233 | 21 | M17122 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | TET2 INCENP PDLIM7 ADAM9 INSR EVI2B PFKFB2 FAM53C MEF2A RUSC2 PTPRS ZBTB21 SIGLEC10 COBL PMAIP1 BAZ2B ZNF521 DENND1A ABCA6 P2RY11 SIPA1L1 ATP1B1 LYN SLX4 | 3.43e-04 | 1250 | 233 | 24 | M41099 |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 3.73e-04 | 195 | 233 | 8 | M7310 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 3.73e-04 | 195 | 233 | 8 | M7382 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 4.00e-04 | 197 | 233 | 8 | M9916 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 4.00e-04 | 197 | 233 | 8 | M7921 | |
| Coexpression | GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN | 4.13e-04 | 198 | 233 | 8 | M9882 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP | 4.13e-04 | 198 | 233 | 8 | M6106 | |
| Coexpression | WANG_LMO4_TARGETS_DN | SYNPO2 INSR AURKA UBR5 PDZD8 BAZ2B DTNA SRFBP1 CASK EIF4G3 ICA1L | 4.16e-04 | 361 | 233 | 11 | M12674 |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN | 4.27e-04 | 199 | 233 | 8 | M6048 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN | 4.27e-04 | 199 | 233 | 8 | M4142 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN | 4.27e-04 | 199 | 233 | 8 | M5707 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | BCLAF1 ITGA6 EWSR1 SH3YL1 NR1D2 DNAJB1 RCAN3 PDE4DIP KDM7A ANKRD36 LCOR | 4.36e-04 | 363 | 233 | 11 | M41103 |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M8048 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN | 4.42e-04 | 200 | 233 | 8 | M9328 | |
| Coexpression | GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP | 4.42e-04 | 200 | 233 | 8 | M4841 | |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M9763 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_DN | 4.42e-04 | 200 | 233 | 8 | M8471 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP | 4.42e-04 | 200 | 233 | 8 | M9860 | |
| Coexpression | GSE557_CIITA_KO_VS_I_AB_KO_DC_DN | 4.42e-04 | 200 | 233 | 8 | M6014 | |
| Coexpression | GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M7369 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN | 4.42e-04 | 200 | 233 | 8 | M6042 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M7436 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 4.42e-04 | 200 | 233 | 8 | M3893 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 4.42e-04 | 200 | 233 | 8 | M7781 | |
| Coexpression | GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN | 4.42e-04 | 200 | 233 | 8 | M7791 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 4.42e-04 | 200 | 233 | 8 | M9258 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M3165 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | KDM5B RPL29 HAUS6 RPS6KA5 TBL1Y CDK19 EVI2B PTPN22 EWSR1 CAGE1 ABCA7 MEF2A GFPT1 LDB1 DCLRE1A NYAP1 NPAT PMS2 MINK1 DOK2 FBXO46 TJP1 NPAS4 TP53 | 4.66e-04 | 1277 | 233 | 24 | MM1032 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | INSR GFPT1 CEP350 USP31 TLN2 TAOK1 CPLANE1 RELCH DPYSL2 APC PAIP1 CASK DCBLD2 | 2.32e-07 | 194 | 232 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | SYNPO2 MYLK INSR GFPT1 CEP350 USP31 ADAMTS15 TLN2 TAOK1 MTCL1 CPLANE1 RELCH DPYSL2 APC PAIP1 CASK DCBLD2 EPHA5 | 6.18e-07 | 408 | 232 | 18 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | BCLAF1 INTS3 MAST4 LDB1 PRRC2A SFSWAP BAZ2B DTNA CAMK2G GTF2I RESF1 BRD2 PAK3 CSPP1 LCOR TP53 | 1.10e-05 | 406 | 232 | 16 | gudmap_developingGonad_e12.5_testes_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | BCLAF1 EWSR1 INTS3 MAST2 MAST4 LDB1 NYNRIN TAOK1 PRRC2A NIPBL SFSWAP BAZ2B DTNA CAMK2G CASK GTF2I RESF1 BRD2 PAK3 CSPP1 LCOR PCM1 TP53 HDLBP | 1.18e-05 | 819 | 232 | 24 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.42e-05 | 165 | 232 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | INSR GFPT1 CEP350 USP31 TLN2 TAOK1 CPLANE1 RELCH DPYSL2 APC PAIP1 CASK C2CD3 PAK3 DCBLD2 | 1.45e-05 | 369 | 232 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | SYNPO2 MYLK INSR GFPT1 USP31 ZNF469 KCNQ5 ADAMTS15 COBL TAOK1 MTCL1 CPLANE1 PAIP1 LPP LCOR HDLBP | 1.72e-05 | 421 | 232 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TANC2 INSR BCL9 HOXA3 CEP350 USP31 PTPRS TAOK1 CPLANE1 RELCH SFSWAP APC C2CD3 GTF2I HDLBP | 2.37e-05 | 385 | 232 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 SYNPO2 MYLK MAP6 INSR BCL9 PTHLH HOXA3 CEP350 USP31 KCNQ5 PTPRS TAOK1 CPLANE1 RELCH SFSWAP APC C2CD3 GTF2I SIPA1L1 FMN2 EPHA5 HDLBP | 3.45e-05 | 818 | 232 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | INSR PFKFB2 CEP350 TAOK1 CPLANE1 RELCH PMS2 APC C2CD3 GTF2I ZC2HC1A FMN2 LCOR HDLBP | 7.03e-05 | 375 | 232 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | TANC2 INSR GFPT1 CEP350 USP31 TAOK1 CPLANE1 RELCH APC PAIP1 GTF2I PAK3 LCOR | 7.45e-05 | 330 | 232 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | INTS3 MAST2 LDB1 PTPRS TAOK1 HEATR5B PRRC2A NIPBL SFSWAP BAZ2B CAMK2G GTF2I BRD2 PCM1 | 7.65e-05 | 378 | 232 | 14 | gudmap_developingGonad_e16.5_testes_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 7.92e-05 | 163 | 232 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CCP110 SP4 EWSR1 SUPT6H PDZD8 PHF21B FNIP2 PCLO APC IGDCC3 DIDO1 PAIP1 GTF3C1 CELSR2 SIPA1L1 MDC1 PAK3 CSPP1 | 1.02e-04 | 595 | 232 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | BCLAF1 INTS3 MAST2 LDB1 PTPRS BAIAP2 PRRC2A NIPBL PMAIP1 SFSWAP BAZ2B DTNA CAMK2G ADGRL1 GTF2I RESF1 BRD2 PAK3 LCOR PCM1 TP53 HDLBP | 1.05e-04 | 822 | 232 | 22 | gudmap_developingGonad_e14.5_ testes_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.06e-04 | 209 | 232 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.06e-04 | 209 | 232 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.10e-04 | 210 | 232 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | BCLAF1 EWSR1 BCL9 INTS3 MAST2 LDB1 NYNRIN PRRC2A SFSWAP BAZ2B CAMK2G GPS2 CASK GTF2I RESF1 BRD2 GTF3C1 CSPP1 LCOR PCM1 TP53 HDLBP | 1.51e-04 | 843 | 232 | 22 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | SYNPO2 MYLK INSR BCL9 CEP350 USP31 ADAMTS15 MTCL1 CPLANE1 RELCH APC C2CD3 SIPA1L1 FMN2 | 1.66e-04 | 407 | 232 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | INSR BCL9 CEP350 USP31 CPLANE1 RELCH APC PAIP1 CASK C2CD3 GTF2I HDLBP | 1.76e-04 | 312 | 232 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | TET2 LEMD3 INSR RUSC2 CEP350 DTNA PCLO ZNF521 ADGRL1 RCAN3 TDRD7 C2CD3 CELSR2 PDE4DIP PAK3 FMN2 KDM7A MAPKBP1 ATP1B1 EPHA5 | 2.18e-04 | 747 | 232 | 20 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SYNPO2 MYLK INSR GFPT1 CEP350 USP31 ADAMTS15 TLN2 TAOK1 MTCL1 CPLANE1 RELCH DPYSL2 APC PAIP1 CASK C2CD3 PAK3 FMN2 DCBLD2 EPHA5 | 2.19e-04 | 806 | 232 | 21 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | SYNPO2 MYLK PDLIM7 INSR BCL9 CEP350 USP31 ADAMTS15 TLN2 MTCL1 CPLANE1 RELCH APC PAIP1 CASK C2CD3 GTF2I SIPA1L1 FMN2 EPHA5 HDLBP | 2.19e-04 | 806 | 232 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | TANC2 SYNPO2 MYLK INSR GFPT1 CEP350 USP31 ZNF469 KCNQ5 ADAMTS15 COBL TAOK1 MTCL1 CPLANE1 APC PAIP1 RESF1 LPP LCOR DCBLD2 HDLBP | 2.38e-04 | 811 | 232 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 2.39e-04 | 149 | 232 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | BCLAF1 EWSR1 INTS3 LDB1 PTPRS PRRC2A SFSWAP BAZ2B CAMK2G CASK GTF2I BRD2 LCOR TP53 | 3.27e-04 | 435 | 232 | 14 | gudmap_developingGonad_e11.5_testes and mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | BCLAF1 EWSR1 BCL9 INTS3 LDB1 NYNRIN SFSWAP CAMK2G GPS2 CASK GTF2I GTF3C1 PCM1 TP53 HDLBP | 4.05e-04 | 498 | 232 | 15 | gudmap_developingGonad_e11.5_testes_k5_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | CCP110 UTP14A ITGA6 UBR5 PHLPP1 TAOK1 TAF4 PHF21B DTNA PCLO CELSR2 PAK3 ATP1B1 | 4.31e-04 | 395 | 232 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | TANC2 INSR GFPT1 CEP350 USP31 TAOK1 CPLANE1 APC PAIP1 RESF1 LCOR DCBLD2 HDLBP | 4.52e-04 | 397 | 232 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | HAUS6 EWSR1 SUPT6H HEATR5B PRIMPOL NPAT FNIP2 APC IGDCC3 DIDO1 SRFBP1 GTF3C1 WDHD1 MDC1 CSPP1 PCM1 | 5.03e-04 | 564 | 232 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SP4 GAPVD1 BCLAF1 TLK1 MAST4 STARD9 TAOK1 CPLANE1 PMS2 SFSWAP BAZ2B DIDO1 CASK RESF1 ZC2HC1A BRD2 LPP CSPP1 LCOR HTT | 5.31e-04 | 801 | 232 | 20 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | SP4 LEMD3 INSR RUSC2 CEP350 MTUS1 DTNA PCLO ADGRL1 RCAN3 C2CD3 CELSR2 PAK3 FMN2 KDM7A MAPKBP1 ATP1B1 EPHA5 | 5.42e-04 | 683 | 232 | 18 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | TANC2 TET2 BCLAF1 INSR USP25 TRIP11 CEP350 MTUS1 NIPBL SLAIN2 BAZ2B WWP1 PCLO LPP ANKRD36 | 1.91e-13 | 199 | 233 | 15 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | TANC2 BCLAF1 INSR TRIP11 CEP350 MTUS1 NIPBL SLAIN2 BAZ2B WWP1 CSPP1 | 8.86e-09 | 199 | 233 | 11 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.45e-08 | 197 | 233 | 10 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-Treg|COVID-19_Mild / Disease, condition lineage and cell class | GPR155 SH3YL1 MAST4 PMAIP1 DNAJB1 GPRIN3 RCAN3 CASK RESF1 ZC2HC1A | 1.09e-07 | 200 | 233 | 10 | c6ae15f7deba26008af5b647855675003bb2ebcd |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.98e-07 | 181 | 233 | 9 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-07 | 184 | 233 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.26e-07 | 186 | 233 | 9 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-Treg|COVID-19_Severe / Disease group, lineage and cell class | 8.16e-07 | 192 | 233 | 9 | 3fb4c148dadcf5e79094e55c6bb53ec7bf9d44c8 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.16e-07 | 192 | 233 | 9 | 7a90ec9fc8f29216c4828e0cf5d040906456e53b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.16e-07 | 192 | 233 | 9 | d883b91bbab71673de4858346d3ab33e5fbbf842 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.01e-06 | 197 | 233 | 9 | c842d169dfce9af3ed7c01dc7e940c0bdd21388c | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-06 | 197 | 233 | 9 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | severe-Treg|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-06 | 198 | 233 | 9 | 377980b9f7d02818e1d145e6884604f8bfacc4f2 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.05e-06 | 198 | 233 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-06 | 199 | 233 | 9 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.10e-06 | 199 | 233 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-06 | 200 | 233 | 9 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-Treg|COVID-19_Severe / Disease, condition lineage and cell class | 1.15e-06 | 200 | 233 | 9 | 2b363f2a1d08019b6ff0b10419870049063cc1cf | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-06 | 177 | 233 | 8 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.79e-06 | 179 | 233 | 8 | 593fc323b28304a57ae162f64b0890b893fff446 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.79e-06 | 179 | 233 | 8 | 708fc0b8ffcb5fac43c52541acb6671fe1cfbb0d | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 5.41e-06 | 182 | 233 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 182 | 233 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.86e-06 | 184 | 233 | 8 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 6.10e-06 | 185 | 233 | 8 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-06 | 187 | 233 | 8 | a525753a8a908ee1ef0b8f06e68855e4af27bf86 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.60e-06 | 187 | 233 | 8 | 9fdfca5b70f585843ef9d810154674a8e561e765 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-06 | 187 | 233 | 8 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-06 | 188 | 233 | 8 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-06 | 188 | 233 | 8 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-06 | 188 | 233 | 8 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COVID-19_Mild-Treg|COVID-19_Mild / Disease condition and Cell class | 7.13e-06 | 189 | 233 | 8 | f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-06 | 189 | 233 | 8 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-06 | 190 | 233 | 8 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.41e-06 | 190 | 233 | 8 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.70e-06 | 191 | 233 | 8 | afff6bfae9a2f1e17d2731315e7fe63c4601679f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.31e-06 | 193 | 233 | 8 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.31e-06 | 193 | 233 | 8 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.31e-06 | 193 | 233 | 8 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.31e-06 | 193 | 233 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.31e-06 | 193 | 233 | 8 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 194 | 233 | 8 | 93bc72a933ccc6a760e5353f072afb606571c6fc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 194 | 233 | 8 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.63e-06 | 194 | 233 | 8 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 9.65e-06 | 197 | 233 | 8 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.65e-06 | 197 | 233 | 8 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | mild-Treg|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.00e-05 | 198 | 233 | 8 | 0269617c0628003d2a13dab98abfd2d15775d16a | |
| ToppCell | severe-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.00e-05 | 198 | 233 | 8 | 4935b40fc848037a06055f30d90bde940b9d5321 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 199 | 233 | 8 | bbb4798d6a24e756fea744a151ba67c1bafbac9a | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.04e-05 | 199 | 233 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-Treg|Control / Disease, condition lineage and cell class | 1.04e-05 | 199 | 233 | 8 | 6b7eb14bf03aa05f2d4ac4f5dd1ccf41a7e47bd1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-05 | 199 | 233 | 8 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-05 | 200 | 233 | 8 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 200 | 233 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 200 | 233 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 200 | 233 | 8 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.63e-05 | 153 | 233 | 7 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-05 | 156 | 233 | 7 | 841d653d74c4de41d2f9a114f6ccb92d6a1ebc24 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.85e-05 | 156 | 233 | 7 | a917b3e799a7b2a3c7f36af61f2b69292c0fb5c0 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-05 | 158 | 233 | 7 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-05 | 159 | 233 | 7 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.09e-05 | 159 | 233 | 7 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 163 | 233 | 7 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-05 | 165 | 233 | 7 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.65e-05 | 165 | 233 | 7 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.65e-05 | 165 | 233 | 7 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 3.09e-05 | 169 | 233 | 7 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-05 | 169 | 233 | 7 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.33e-05 | 171 | 233 | 7 | cafcb7714110cb361808dbe4b9a4963bb71f5129 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 171 | 233 | 7 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 172 | 233 | 7 | 10a1d1838492b8ce6dea08844353b51571432c56 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 3.46e-05 | 172 | 233 | 7 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 172 | 233 | 7 | d824e46c8040b0bb9235f9b8a2b35386b303caa0 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 3.46e-05 | 172 | 233 | 7 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-05 | 174 | 233 | 7 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 174 | 233 | 7 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 178 | 233 | 7 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-05 | 178 | 233 | 7 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.61e-05 | 180 | 233 | 7 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.78e-05 | 181 | 233 | 7 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.95e-05 | 182 | 233 | 7 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.12e-05 | 183 | 233 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-05 | 183 | 233 | 7 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.12e-05 | 183 | 233 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 184 | 233 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 184 | 233 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.30e-05 | 184 | 233 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-05 | 184 | 233 | 7 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 184 | 233 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 185 | 233 | 7 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.49e-05 | 185 | 233 | 7 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 185 | 233 | 7 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 185 | 233 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-05 | 186 | 233 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.68e-05 | 186 | 233 | 7 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.68e-05 | 186 | 233 | 7 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 5.87e-05 | 187 | 233 | 7 | bda716a64262325e6e68b281caf131f1840fd298 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.87e-05 | 187 | 233 | 7 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | LEMD3 PDLIM7 RUSC2 TLK1 LDB1 MTUS1 UBR5 RECQL5 CAMK2G TEP1 CASK MAPKBP1 ATP1B1 | 1.07e-07 | 196 | 230 | 13 | 6155_DN |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | PDLIM7 INSR MAST2 LDB1 SUPT6H BRPF1 RECQL5 DPYSL2 ADGRL1 TEP1 THBS3 PDE4DIP | 6.68e-07 | 193 | 230 | 12 | 7232_DN |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | EMC1 UTP14A CC2D1A BCL9 NEK9 MAST4 TLN2 BAIAP2 DTNA MINK1 WDHD1 LPP | 9.25e-07 | 199 | 230 | 12 | 6069_DN |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | UBAP2 ACACB CDK19 LDB1 TLN2 CAMK2G PCLO MINK1 TRIOBP E2F4 CSPP1 INPP5J | 9.25e-07 | 199 | 230 | 12 | 4843_DN |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | PDLIM7 INSR ABCA7 MTUS1 PTPRS SUPT6H TLN2 DCLRE1A E2F4 CELSR2 LPP PDE4DIP | 9.25e-07 | 199 | 230 | 12 | 7290_UP |
| Drug | geldanamycin | TET2 SP4 USP25 PTHLH TLK1 NIPBL SLAIN2 RFX7 CASK RESF1 CDK13 LPP PDE4DIP PCM1 TP53 HTT | 1.30e-06 | 371 | 230 | 16 | ctd:C001277 |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; HL60; HG-U133A | EMC1 PDLIM7 SUPT6H CIZ1 NIPBL NPAT DNAJB1 SFSWAP EP400 GTF3C1 MAPKBP1 | 4.80e-06 | 194 | 230 | 11 | 2042_DN |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HG-U133A | EMC1 PDLIM7 BRAP MAST4 CIZ1 NIPBL EP400 TMEM51 GPS2 DIDO1 MAPKBP1 | 4.80e-06 | 194 | 230 | 11 | 1884_DN |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A | UBAP2 ACACB MAST2 RUSC2 SUPT6H CIZ1 BAIAP2 OCEL1 PCLO CEP131 EIF4G3 | 5.04e-06 | 195 | 230 | 11 | 6339_DN |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | PDLIM7 UTP14A CC2D1A ABCA7 NEK9 LDB1 DTNA MINK1 MEGF8 KDM7A MAPKBP1 | 5.04e-06 | 195 | 230 | 11 | 6191_DN |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A | INCENP ITGA6 MEF2A MTUS1 TLN2 PMAIP1 MINK1 E2F4 APOD THBS3 PDE4DIP | 5.29e-06 | 196 | 230 | 11 | 6462_DN |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | EMC1 RPS6KA5 MAST2 TLN2 NPAT CAMK2G E2F4 SPECC1L SIPA1L1 CEP131 HTT | 5.55e-06 | 197 | 230 | 11 | 7011_DN |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | TBL1Y UTP14A EVI2B MEF2A LDB1 MTUS1 TLN2 DTNA THBS3 LPP PCDH1 | 5.55e-06 | 197 | 230 | 11 | 4001_UP |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A | ACACB TBL1Y PTHLH NPAT CAMK2G MINK1 APC ADGRL1 CDK13 IL6R INPP5J | 5.55e-06 | 197 | 230 | 11 | 2782_UP |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | INCENP TRIP11 MAST4 NR1D2 CAMK2G ADGRL1 THBS3 LPP MAPKBP1 CSPP1 PCM1 | 5.83e-06 | 198 | 230 | 11 | 1538_DN |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | PDLIM7 MAST2 MAST4 SUPT6H PRRC2A DTNA TMEM51 ADGRL1 PDE4DIP CSPP1 IL6R | 5.83e-06 | 198 | 230 | 11 | 7018_UP |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | PDLIM7 CDK19 UTP14A PTPN22 NEK9 TLK1 DTNA E2F4 GTF2I GTF3C1 PDE4DIP | 6.12e-06 | 199 | 230 | 11 | 3079_DN |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | ITGA6 BCL9 MAST2 PMS2 CAMK2G PCLO MINK1 APC PPP2R5D LYN CSPP1 | 6.12e-06 | 199 | 230 | 11 | 5513_DN |
| Drug | LGD2226 | 6.65e-06 | 46 | 230 | 6 | CID011560224 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.55e-05 | 180 | 230 | 10 | 4541_DN | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | RPS6KA5 PDLIM7 MAST4 SUPT6H PMAIP1 BAZ2B DTNA MAPKBP1 LYN PCM1 | 1.97e-05 | 185 | 230 | 10 | 944_UP |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A | 2.26e-05 | 188 | 230 | 10 | 7097_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.26e-05 | 188 | 230 | 10 | 5116_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | EWSR1 MEF2A CEP350 BRPF1 RFX7 GTF2I ZC2HC1A PDE4DIP EIF4G3 ATP1B1 | 2.37e-05 | 189 | 230 | 10 | 1045_DN |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | INCENP PDLIM7 CDK19 PMS2 DTNA CAMK2G MINK1 TEP1 PDE4DIP CSPP1 | 2.59e-05 | 191 | 230 | 10 | 5214_DN |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | CCP110 ACACB PTPN14 SUPT6H BRPF1 DCLRE1A FBXO46 RCAN3 CEP131 CSPP1 | 2.84e-05 | 193 | 230 | 10 | 1805_DN |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | INCENP CDK19 PTHLH RUSC2 MAST4 LDB1 SUPT6H ADGRL1 THBS3 PCM1 | 2.84e-05 | 193 | 230 | 10 | 4558_DN |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | EMC1 ACACB CDK19 MAST2 BAIAP2 NIPBL DNAJB1 EP400 DTNA CELSR2 | 2.84e-05 | 193 | 230 | 10 | 544_UP |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | INCENP PFKFB2 MAST2 MTUS1 RECQL5 BAIAP2 DTNA E2F4 THBS3 PDE4DIP | 2.84e-05 | 193 | 230 | 10 | 2682_UP |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.96e-05 | 194 | 230 | 10 | 4422_DN | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A | 3.10e-05 | 195 | 230 | 10 | 1156_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | ACACB BCL9 TRIP11 TLK1 LDB1 RECQL5 ADGRL1 SIPA1L1 KDM7A DCBLD2 | 3.10e-05 | 195 | 230 | 10 | 3478_UP |
| Drug | Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.10e-05 | 195 | 230 | 10 | 3519_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.10e-05 | 195 | 230 | 10 | 5004_DN | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; PC3; HT_HG-U133A | INCENP CDK19 RUSC2 MTUS1 RECQL5 PCLO TRIOBP GTF2I PAK3 EPHA5 | 3.10e-05 | 195 | 230 | 10 | 4224_DN |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | GAPVD1 PFKFB2 BRAP MAST4 SUPT6H NIPBL NPAT EP400 DTNA ADGRL1 | 3.10e-05 | 195 | 230 | 10 | 667_DN |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | 3.10e-05 | 195 | 230 | 10 | 7372_UP | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | PDLIM7 PTHLH SUPT6H BAIAP2 NR1D2 FBXO46 RCAN3 PPP2R5D WDHD1 EIF4G3 | 3.23e-05 | 196 | 230 | 10 | 1794_DN |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.23e-05 | 196 | 230 | 10 | 7360_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.23e-05 | 196 | 230 | 10 | 3271_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 3.23e-05 | 196 | 230 | 10 | 2086_UP | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A | PDLIM7 CDK19 ABCA7 MTUS1 NIPBL DIDO1 E2F4 RCAN3 THBS3 GTF3C1 | 3.23e-05 | 196 | 230 | 10 | 3093_DN |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A | RPS6KA5 PDLIM7 INSR LDB1 SUPT6H NPAT OCEL1 CAMK2G MAPKBP1 INVS | 3.23e-05 | 196 | 230 | 10 | 5294_DN |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; HL60; HT_HG-U133A | 3.23e-05 | 196 | 230 | 10 | 2196_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | PFKFB2 MAST2 NEK9 BRAP CEP350 SUPT6H APC FBXO46 THBS3 CEP131 | 3.23e-05 | 196 | 230 | 10 | 2099_DN |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | MYLK ACACB CC2D1A PTPN22 PTPN14 DTNA SIPA1L1 PDE4DIP INPP5J PCM1 | 3.23e-05 | 196 | 230 | 10 | 6065_DN |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; PC3; HT_HG-U133A | EMC1 MYLK PDLIM7 CC2D1A TRIP11 PRRC2A GPS2 FBXO46 PDE4DIP EIF4G3 | 3.23e-05 | 196 | 230 | 10 | 7257_DN |
| Drug | LY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.23e-05 | 196 | 230 | 10 | 1216_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A | RPS6KA5 PDLIM7 LDB1 MTUS1 MINK1 APC TDRD7 PPP2R5D WDHD1 PCM1 | 3.23e-05 | 196 | 230 | 10 | 4815_DN |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | EMC1 MAST2 RECQL5 BAIAP2 NIPBL PMAIP1 NR1D2 MINK1 RESF1 CSPP1 | 3.23e-05 | 196 | 230 | 10 | 4374_DN |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | CC2D1A EWSR1 MAST2 TRIP11 ABCA7 MEF2A RUSC2 MTUS1 PMS2 CAMK2G | 3.38e-05 | 197 | 230 | 10 | 4606_DN |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; HL60; HT_HG-U133A | 3.38e-05 | 197 | 230 | 10 | 2738_DN | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 3.38e-05 | 197 | 230 | 10 | 3544_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; HL60; HG-U133A | 3.38e-05 | 197 | 230 | 10 | 2037_DN | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; HL60; HT_HG-U133A | 3.38e-05 | 197 | 230 | 10 | 1319_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; HL60; HT_HG-U133A | 3.38e-05 | 197 | 230 | 10 | 1322_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | PDLIM7 RUSC2 CEP350 MAST4 SUPT6H NIPBL NPAT ADGRL1 DIDO1 RCAN3 | 3.38e-05 | 197 | 230 | 10 | 2070_DN |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | MAST2 CEP350 MAST4 TLN2 PMAIP1 CELSR2 CDK13 PDE4DIP EIF4G3 ATP1B1 | 3.53e-05 | 198 | 230 | 10 | 6239_UP |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A | PDLIM7 PTPN22 BRAP AURKA SUPT6H TLN2 BAIAP2 APC SIPA1L1 PDE4DIP | 3.53e-05 | 198 | 230 | 10 | 5361_UP |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 5259_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 4992_DN | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 3282_DN | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 7416_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 5246_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 6080_DN | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 6327_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 3.53e-05 | 198 | 230 | 10 | 4592_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | RPS6KA5 MAST2 PHLPP1 TLN2 MTCL1 EP400 DTNA SIPA1L1 LPP MAPKBP1 | 3.68e-05 | 199 | 230 | 10 | 7020_DN |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | EMC1 PTPN22 PTHLH MAST4 RECQL5 BAIAP2 PMAIP1 SIPA1L1 MAPKBP1 INPP5J | 3.68e-05 | 199 | 230 | 10 | 5443_DN |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | PDLIM7 MAST2 TRIP11 LDB1 PTPRS PHLPP1 MTCL1 TMEM51 MINK1 IL6R | 3.68e-05 | 199 | 230 | 10 | 6004_DN |
| Drug | Arecoline hydrobromide [300-08-3]; Down 200; 17uM; PC3; HT_HG-U133A | 3.68e-05 | 199 | 230 | 10 | 6322_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; PC3; HG-U133A | 3.68e-05 | 199 | 230 | 10 | 1915_UP | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | INCENP MAST2 MEF2A MAST4 APC MEGF8 PDE4DIP CEP131 CSPP1 PCM1 | 3.68e-05 | 199 | 230 | 10 | 6674_DN |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | PDLIM7 NEK9 PTHLH RECQL5 PMAIP1 ADGRL1 RCAN3 SIPA1L1 PDE4DIP MAPKBP1 | 3.68e-05 | 199 | 230 | 10 | 5458_DN |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HG-U133A | 3.68e-05 | 199 | 230 | 10 | 1945_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; HL60; HT_HG-U133A | ACACB TRIP11 NEK9 RECQL5 DTNA CAMK2G MINK1 APC RCAN3 MAPKBP1 | 3.84e-05 | 200 | 230 | 10 | 2197_DN |
| Drug | Clorgyline | 5.51e-05 | 168 | 230 | 9 | ctd:D003010 | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.38e-05 | 180 | 230 | 9 | 7356_UP | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.16e-04 | 185 | 230 | 9 | 7209_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.36e-04 | 189 | 230 | 9 | 4672_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 1.36e-04 | 189 | 230 | 9 | 6649_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.36e-04 | 189 | 230 | 9 | 5084_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.41e-04 | 190 | 230 | 9 | 7305_DN | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.47e-04 | 191 | 230 | 9 | 4981_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.47e-04 | 191 | 230 | 9 | 5200_DN | |
| Drug | Magnetite Nanoparticles | GPR155 TET2 HAUS6 MYLK RPS6KA5 LEMD3 PDLIM7 BCLAF1 PTPN22 TRIP11 MEF2A PTPN14 STARD9 MMP12 NR1D2 BAZ2B WWP1 TMEM51 RFX7 CASK WDHD1 PDE4DIP KDM7A ATP1B1 DCBLD2 IL6R PCM1 TP53 | 1.49e-04 | 1310 | 230 | 28 | ctd:D058185 |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 1.53e-04 | 192 | 230 | 9 | 1599_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.53e-04 | 192 | 230 | 9 | 5238_UP | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.53e-04 | 192 | 230 | 9 | 7191_UP | |
| Drug | 5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA | 1.53e-04 | 192 | 230 | 9 | 960_UP | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 193 | 230 | 9 | 5989_DN | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 1.59e-04 | 193 | 230 | 9 | 7059_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.59e-04 | 193 | 230 | 9 | 2076_DN | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.59e-04 | 193 | 230 | 9 | 2098_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 193 | 230 | 9 | 2833_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.59e-04 | 193 | 230 | 9 | 4338_DN | |
| Drug | semustine; Down 200; 100uM; PC3; HT_HG-U133A | 1.65e-04 | 194 | 230 | 9 | 7492_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.65e-04 | 194 | 230 | 9 | 4281_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.65e-04 | 194 | 230 | 9 | 2430_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.65e-04 | 194 | 230 | 9 | 1707_DN | |
| Disease | pulse pressure measurement | TET2 HAUS6 INSR MAST2 NEK9 PTHLH HOXA3 LDB1 KCNQ5 SUPT6H MYPN ADAMTS15 TLN2 DCLRE1A SLAIN2 COL27A1 TRIOBP SRFBP1 MEGF8 LPP PITPNM3 KIAA1755 ATP1B1 PCM1 TP53 | 8.93e-05 | 1392 | 229 | 25 | EFO_0005763 |
| Disease | Adenocarcinoma of large intestine | 1.06e-04 | 96 | 229 | 6 | C1319315 | |
| Disease | mean reticulocyte volume | ABCA7 BRAP CEP350 ZNF469 LDB1 NYNRIN TLN2 TAF4 EP400 E2F4 SPECC1L RESF1 GTF3C1 LYN PCM1 TP53 HDLBP | 1.84e-04 | 799 | 229 | 17 | EFO_0010701 |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.40e-04 | 16 | 229 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 2.47e-04 | 72 | 229 | 5 | DOID:10534 (is_implicated_in) | |
| Disease | chronic lymphocytic leukemia | 3.42e-04 | 119 | 229 | 6 | EFO_0000095 | |
| Disease | Central Nervous System Neoplasms | 3.56e-04 | 4 | 229 | 2 | C0085136 | |
| Disease | body weight | TET2 GAPVD1 EPHA6 RPS6KA5 INSR BRAP PTPN14 MAST4 KCNQ5 KIAA1328 TLN2 BAIAP2 NIPBL RELCH ZNF280C ZNF521 DENND1A ZC2HC1A LPP LCOR PCM1 TP53 | 3.57e-04 | 1261 | 229 | 22 | EFO_0004338 |
| Disease | Turcot syndrome (disorder) | 5.91e-04 | 5 | 229 | 2 | C0265325 | |
| Disease | Glioma | 5.94e-04 | 87 | 229 | 5 | C0017638 | |
| Disease | Colorectal cancer | 1.18e-03 | 27 | 229 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 1.18e-03 | 27 | 229 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 1.18e-03 | 27 | 229 | 3 | cv:C0009404 | |
| Disease | arteriovenous malformations of the brain (implicated_via_orthology) | 1.23e-03 | 7 | 229 | 2 | DOID:0060688 (implicated_via_orthology) | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 1.23e-03 | 7 | 229 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | Cone-Rod Dystrophy 2 | 1.45e-03 | 29 | 229 | 3 | C3489532 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 1.63e-03 | 8 | 229 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | Ependymoblastoma | 1.63e-03 | 8 | 229 | 2 | C0700367 | |
| Disease | cleft palate (implicated_via_orthology) | 1.63e-03 | 8 | 229 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | myasthenia gravis (is_implicated_in) | 1.63e-03 | 8 | 229 | 2 | DOID:437 (is_implicated_in) | |
| Disease | Neuroectodermal Tumor, Primitive | 1.63e-03 | 8 | 229 | 2 | C0206663 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 1.63e-03 | 8 | 229 | 2 | C0796250 | |
| Disease | Cerebral Primitive Neuroectodermal Tumor | 1.63e-03 | 8 | 229 | 2 | C0751675 | |
| Disease | Spongioblastoma | 1.63e-03 | 8 | 229 | 2 | C0334584 | |
| Disease | Medulloepithelioma | 1.63e-03 | 8 | 229 | 2 | C0334596 | |
| Disease | Ewings sarcoma | 1.63e-03 | 8 | 229 | 2 | C0553580 | |
| Disease | vital capacity | TET2 GLDN TRIP11 PTHLH GFPT1 HOXA3 KCNQ5 MYPN ADAMTS15 MTCL1 CAMK2G PCLO GPRIN3 C16orf96 IRX1 HGS MAPKBP1 ZNF853 ICA1L NPAS4 | 1.64e-03 | 1236 | 229 | 20 | EFO_0004312 |
| Disease | neuroticism measurement, cognitive function measurement | TET2 SYNGAP1 KIAA1328 BAIAP2 NR1D2 PCLO APC DENND1A NCOA5 GTF3C1 SIPA1L1 EIF4G3 | 1.67e-03 | 566 | 229 | 12 | EFO_0007660, EFO_0008354 |
| Disease | cortical surface area measurement | TANC2 TET2 SP4 SKIDA1 MAST2 PTHLH ZNF469 MAST4 TLN2 MTCL1 PRRC2A FNIP2 DHX16 DPYSL2 BAZ2B APC TRIOBP DENND1A TJP1 MDC1 KIAA1755 | 1.94e-03 | 1345 | 229 | 21 | EFO_0010736 |
| Disease | schizophrenia (implicated_via_orthology) | 1.95e-03 | 68 | 229 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | HEPATOCELLULAR CARCINOMA | 2.08e-03 | 9 | 229 | 2 | 114550 | |
| Disease | Lynch Syndrome | 2.08e-03 | 9 | 229 | 2 | C4552100 | |
| Disease | octanoylcarnitine measurement | 2.08e-03 | 9 | 229 | 2 | EFO_0021042 | |
| Disease | Hepatocellular carcinoma | 2.08e-03 | 9 | 229 | 2 | cv:C2239176 | |
| Disease | Glaucoma | 2.08e-03 | 9 | 229 | 2 | C0017601 | |
| Disease | Polydactyly | 2.23e-03 | 117 | 229 | 5 | C0152427 | |
| Disease | Leukemia, Myelocytic, Acute | 2.38e-03 | 173 | 229 | 6 | C0023467 | |
| Disease | triple-negative breast cancer | 2.59e-03 | 10 | 229 | 2 | EFO_0005537 | |
| Disease | B-lymphoblastic leukemia/lymphoma (is_implicated_in) | 2.59e-03 | 10 | 229 | 2 | DOID:0080630 (is_implicated_in) | |
| Disease | neutrophil percentage of leukocytes | TET2 PSMD2 ABCA7 BRAP HOXA3 BAZ2B MINK1 DOK2 ZC2HC1A GTF3C1 CDK13 HTT | 3.08e-03 | 610 | 229 | 12 | EFO_0007990 |
| Disease | trimethyllysine measurement | 3.15e-03 | 11 | 229 | 2 | EFO_0009134 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.15e-03 | 11 | 229 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | mosaic loss of chromosome Y measurement | 3.53e-03 | 80 | 229 | 4 | EFO_0007783 | |
| Disease | ciliopathy (implicated_via_orthology) | 3.69e-03 | 40 | 229 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | multiple system atrophy | 3.69e-03 | 40 | 229 | 3 | EFO_1001050 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 3.76e-03 | 12 | 229 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | gallbladder carcinoma (is_marker_for) | 3.76e-03 | 12 | 229 | 2 | DOID:4948 (is_marker_for) | |
| Disease | Thrombocythemia, Essential | 3.76e-03 | 12 | 229 | 2 | C0040028 | |
| Disease | Hodgkins lymphoma | 3.85e-03 | 82 | 229 | 4 | EFO_0000183 | |
| Disease | ovarian neoplasm | 4.00e-03 | 134 | 229 | 5 | C0919267 | |
| Disease | total hip arthroplasty, osteoarthritis | 4.24e-03 | 42 | 229 | 3 | EFO_0009806, MONDO_0005178 | |
| Disease | very low density lipoprotein cholesterol measurement | 4.35e-03 | 260 | 229 | 7 | EFO_0008317 | |
| Disease | Malignant neoplasm of ovary | 4.40e-03 | 137 | 229 | 5 | C1140680 | |
| Disease | Benign tumor of pancreas | 4.42e-03 | 13 | 229 | 2 | C0347284 | |
| Disease | Genetic chronic primary adrenal insufficiency | 4.42e-03 | 13 | 229 | 2 | Orphanet_101960 | |
| Disease | Skin Abnormalities | 4.42e-03 | 13 | 229 | 2 | C0037268 | |
| Disease | Congenital Heart Defects | 4.83e-03 | 44 | 229 | 3 | C0018798 | |
| Disease | Leber hereditary optic neuropathy (is_implicated_in) | 5.13e-03 | 14 | 229 | 2 | DOID:705 (is_implicated_in) | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 5.13e-03 | 14 | 229 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | 5-methyluridine (ribothymidine) measurement | 5.13e-03 | 14 | 229 | 2 | EFO_0020013 | |
| Disease | Gastric Adenocarcinoma | 5.15e-03 | 45 | 229 | 3 | C0278701 | |
| Disease | osteoarthritis, hip | 5.80e-03 | 92 | 229 | 4 | EFO_1000786 | |
| Disease | total lipids in small LDL | 5.82e-03 | 47 | 229 | 3 | EFO_0022168 | |
| Disease | Meckel-Gruber syndrome | 5.89e-03 | 15 | 229 | 2 | C0265215 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 5.89e-03 | 15 | 229 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | alkaline phosphatase measurement | TET2 EMC1 ACACB RPS6KA5 PTPN22 TLK1 NYNRIN MINK1 GPS2 ABCA6 FGFBP3 FMN2 EIF4G3 DCBLD2 IL6R HDLBP | 6.02e-03 | 1015 | 229 | 16 | EFO_0004533 |
| Disease | Neurodevelopmental Disorders | 6.02e-03 | 93 | 229 | 4 | C1535926 | |
| Disease | mean platelet volume | TET2 HAUS6 UTP14A ITGA6 PSMD2 TLK1 MAST4 TAOK1 CHMP4C PCDHGA7 DOK2 CKAP2L LYN ICA1L IL6R HTT | 6.30e-03 | 1020 | 229 | 16 | EFO_0004584 |
| Disease | diastolic blood pressure, systolic blood pressure | GAPVD1 CAGE1 BCL9 SH3YL1 CEP350 ADAMTS15 TLN2 VWA3B C16orf96 C2CD3 PCM1 TP53 | 6.42e-03 | 670 | 229 | 12 | EFO_0006335, EFO_0006336 |
| Disease | phospholipids in medium LDL measurement | 6.54e-03 | 49 | 229 | 3 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 6.54e-03 | 49 | 229 | 3 | EFO_0022224 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1 measurement | 6.70e-03 | 16 | 229 | 2 | EFO_0008062 | |
| Disease | peanut allergy measurement | 6.70e-03 | 16 | 229 | 2 | EFO_0007017 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.78e-03 | 152 | 229 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 6.91e-03 | 50 | 229 | 3 | C0025149 | |
| Disease | Benign neoplasm of stomach | 7.55e-03 | 17 | 229 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 7.55e-03 | 17 | 229 | 2 | C0496905 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 7.55e-03 | 17 | 229 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Carcinoma in situ of stomach | 7.55e-03 | 17 | 229 | 2 | C0154060 | |
| Disease | visfatin measurement | 7.55e-03 | 17 | 229 | 2 | EFO_0801230 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 7.55e-03 | 17 | 229 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 7.62e-03 | 220 | 229 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | total lipids in medium LDL | 7.71e-03 | 52 | 229 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 7.71e-03 | 52 | 229 | 3 | EFO_0022308 | |
| Disease | coronary artery disease (is_implicated_in) | 7.75e-03 | 100 | 229 | 4 | DOID:3393 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RNPNLPPETVDSLKN | 151 | P05090 | |
| PTRPQDGNKPTETSQ | 136 | Q01844 | |
| RDKPTNNFPKNQTPV | 446 | O60825 | |
| LPPKVSAAFSSQQQP | 466 | Q96L91 | |
| VASAPTKPQSPAQNA | 746 | Q96L91 | |
| AQVPASSDSPSQQPK | 3126 | Q96L91 | |
| INAAPDSPSKQLPDQ | 111 | Q7Z569 | |
| PQIQKTEISFRPNDP | 81 | P05026 | |
| SIAKESALNPSQPPS | 211 | Q8TC20 | |
| SQDSSLNQVPPNKKP | 426 | Q9BWU1 | |
| PLNNTQKSKQPLPSA | 91 | O14965 | |
| ATPAQPISAKATQPS | 781 | A6NCI8 | |
| VAQTPRRTAPAKQAP | 351 | Q9BXI3 | |
| NANREEPVSLTFPNP | 351 | O94910 | |
| PVPQNEKATSAQPAA | 1681 | Q9UIF8 | |
| RPPSAPRNAISNVNE | 356 | P54756 | |
| PSQQLRAPSAFPAVQ | 206 | Q13227 | |
| VFRISPQSRDAKPNP | 1231 | Q8N139 | |
| ASQVPNPAAAAIPRT | 851 | Q69YQ0 | |
| PQAQSQPPSSNKRPS | 46 | Q14738 | |
| APPQDPASSARNKRS | 81 | Q6ZMI3 | |
| PINSNPVSSQKQPAL | 261 | A6QL64 | |
| RKRNVNTAPQFQPPS | 171 | Q9HCU4 | |
| AAAPSQPLRIQAQDP | 376 | Q9HBB8 | |
| EPSAPPTSTQAQQKE | 376 | O60231 | |
| NRQDVPKTTPSLPQG | 256 | Q6ZUS5 | |
| SAQEPARKKQDPPVT | 151 | P25685 | |
| KPASTGPDPLVQQRN | 86 | Q13319 | |
| PNVPSSSLPAQPNRK | 186 | Q96CF2 | |
| KQTDPSTPQQESSKP | 1141 | Q14004 | |
| ISPLPNASAPAAQRN | 136 | Q8TE58 | |
| RSTAQPQPTKQSPLE | 136 | Q8IZY2 | |
| PASQVVRKERNPNPN | 111 | P0C854 | |
| QRVNVQKPPFSSPTL | 71 | Q5T7V8 | |
| QKIAQTRRPDPPTAA | 216 | Q9UKA8 | |
| KENLPSIQQAPPNTD | 801 | Q9Y5G6 | |
| FQKSPQNHRPPSVSD | 1291 | A6NNM3 | |
| FQKSPQNHRPPSVSD | 1291 | A6NJZ7 | |
| PRSRKNATQPPNAEE | 996 | Q68E01 | |
| KENQRLPNPDNSEPA | 266 | P39900 | |
| RKPLPKADQPNNRTS | 1716 | Q9Y4B5 | |
| PPPQSQKEAQVAARV | 201 | Q9H607 | |
| CPPNKPAESVQSNNS | 766 | Q9Y2R2 | |
| NSPPNSLTPCLKIRN | 776 | Q9Y2U8 | |
| PNVSSTLKPPSNNAI | 1101 | Q14207 | |
| HQKPPRNPLSSSDAA | 96 | O00763 | |
| STIPKENSPNSFPRR | 446 | Q9P260 | |
| PNKEVTPPSAENANS | 231 | O75914 | |
| NTKSSPQIRNPPSDA | 391 | O14936 | |
| PQIRNPPSDAVQRAK | 396 | O14936 | |
| QSAPPKENPSERKTN | 191 | Q8TAT2 | |
| LNATAAPKPSEPQSR | 356 | Q96G91 | |
| AISAQKNAAPATPQP | 241 | O60496 | |
| RPASNPPPISNQATK | 896 | Q6ZMT4 | |
| QNPQPGDSRSQKPEL | 411 | A5PL33 | |
| NSQPQPPRESKLESC | 311 | Q15746 | |
| KDVENQLSPPQGPRS | 671 | Q8IVU1 | |
| PCSAPLEPKSQASRN | 1741 | Q14676 | |
| QQAQPALAPPSARAV | 51 | Q96JE9 | |
| NSKPPSSQESKSENP | 391 | Q86U70 | |
| HKPQVEASSPRLNPA | 861 | Q8TD19 | |
| ASNNPTPANAAKSPL | 131 | O43365 | |
| TEIANSTPNPKPAAS | 406 | Q9NQS7 | |
| KNPRSLCIQPQTAPD | 881 | Q9ULD2 | |
| TSPAKQQAPPVRNLH | 521 | Q16555 | |
| KSPEQSPPAINANTL | 836 | Q7Z3F1 | |
| VNLKAPTHNSERPPQ | 356 | Q5JYT7 | |
| TIANQINTAPKPAAP | 731 | Q9NR82 | |
| NTPQLSPATTPANKK | 461 | Q14C86 | |
| PAKPSAQQSTKPVSQ | 546 | Q9Y6V0 | |
| TPQQSPKPQEQSRRF | 891 | Q9Y6V0 | |
| SQPPAVPDNRRQAES | 356 | Q15154 | |
| SQNQPRPPSAALKPS | 21 | Q6PJ61 | |
| DPSQPNSTKNQSLPK | 21 | Q96JN0 | |
| PSIQLQPQSPSASKK | 976 | Q08174 | |
| QAKVPLPSADAPNQA | 596 | Q8NEN9 | |
| PSAPPTSQQELQAKI | 421 | Q9HCD5 | |
| PSRKQITVHNPSTQP | 156 | P34910 | |
| SRAQSPPVPARKNQL | 916 | Q1MSJ5 | |
| PASKSNPEATNQPVT | 606 | Q9H0H0 | |
| SKTPITPQDINRPLN | 401 | Q6KC79 | |
| SSLKGSPEPNQQPEA | 131 | Q9BYJ0 | |
| LTFQQPPNTSQPDKV | 686 | Q7Z7M0 | |
| DQRAKQPPSTFVPQI | 336 | Q7LBC6 | |
| NPSISVSTQQPPKKF | 31 | Q93052 | |
| LAKPSPAQQTDRSSP | 1371 | Q9UGL1 | |
| PTKTLQPSNPADSNN | 776 | O75582 | |
| IDPPLRSNDPKSQNH | 561 | P06213 | |
| TVTNSPSNPRNPTKD | 716 | P23229 | |
| RALPNNTSSSPQPKK | 306 | P04637 | |
| TNQNISIKSEPISPP | 396 | Q02078 | |
| SPKPEVRAPQQASFS | 46 | Q96MM6 | |
| PVQSKPQKASAPAAD | 86 | Q9NR12 | |
| LVQSLSPNSAPKPQR | 516 | Q86T90 | |
| APPSSQDKIPQQNSE | 96 | Q9H074 | |
| QRTLQSKPSAPPQDV | 611 | Q13332 | |
| SQTFPEQLSPNPTKT | 546 | Q8IUM7 | |
| ARKNAQPSPARAPAE | 6 | Q13794 | |
| PSQTKLQARAPNPTA | 81 | Q8IV32 | |
| NPAVSCLEQQPRNKP | 2521 | P42858 | |
| PDPPANITVTAVARN | 216 | P08887 | |
| SADNQVPPPVSAALQ | 1796 | Q9P2D3 | |
| PQSFQPAAATQKLRP | 896 | Q9BX69 | |
| QNLVLPNRKSPSPVA | 761 | Q4AC94 | |
| PALAQSQEASRPNSP | 231 | Q16254 | |
| QAVSLSRAQEPAQPP | 296 | A6NNT2 | |
| PAPTPQKTQRNEFTA | 2021 | Q9H799 | |
| RPNPAQSLKLDAQSP | 191 | Q8IZ16 | |
| DVAQDPQVSRSPFKP | 756 | Q9P278 | |
| NTQISALRNDPKPLP | 221 | O00512 | |
| PSRRSPAKTIAPQNA | 296 | Q9NYF8 | |
| QNPESRLQADPKPIS | 801 | O75128 | |
| RLQADPKPISPQQKS | 806 | O75128 | |
| PESPKAQASSVPTAQ | 101 | P01880 | |
| APPKATSTRAQQQLA | 481 | Q6P1N0 | |
| LKPQQASQAPTAPSV | 341 | Q5T0F9 | |
| SKEVPLPNPRNSQSK | 6 | Q5VT06 | |
| KPNAPLTDLNPAASR | 1291 | Q5VT06 | |
| QQEQQSADKPASLPP | 1536 | Q9BTC0 | |
| AQAPTKQPPRSSPNT | 311 | P11229 | |
| KNQANPSRQPGSVPR | 741 | Q13443 | |
| QKPSQSRVPNRVPVS | 981 | O43303 | |
| RTPRPAAAQPSQKIT | 346 | Q8IZC6 | |
| PTSNKQQRPVPESQL | 36 | P07948 | |
| LENTTPAQPKNLSPR | 1686 | Q6P0Q8 | |
| NLSPREQGKTQPPSA | 1696 | Q6P0Q8 | |
| QNVGRDVTKPSPAPN | 2576 | O15021 | |
| ETSLTSQNEKPPRPQ | 906 | O60336 | |
| TLQPSAPQQARDPFE | 961 | Q8TEH3 | |
| SQPTPEKAQQNPTLL | 501 | Q9Y4J8 | |
| PPASSPNKDVQAVAS | 401 | Q8NFN8 | |
| RHKPELSPTPQNVQT | 861 | Q7Z4H7 | |
| GPAPQTVEKNSRPQE | 256 | Q5JT82 | |
| VLPTQPNPVDASRAQ | 276 | Q8N766 | |
| PRNSNDLKNTTAPPK | 466 | Q96PD2 | |
| APKFTQPLQPRSSNE | 486 | Q96PD2 | |
| NPVPSPNQKRSSQCK | 586 | Q6PJP8 | |
| SAANPTPSPIRKNQE | 576 | Q6ZVF9 | |
| SKSPPRKINSSPNVN | 821 | P78347 | |
| NQPVPSQSPKKLTRS | 431 | Q8NDH6 | |
| KAQDEPSSKTPSPQN | 231 | D6RIA3 | |
| HSPSQSPNQSPRIKR | 431 | Q9NZ56 | |
| PSRGNSPKEQPFSQV | 81 | Q9NYF3 | |
| SQEKPQVLTPSPRKQ | 236 | Q9UKG4 | |
| TPSERAPPLKSSNQT | 191 | Q9UPN4 | |
| APPLKSSNQTAPSLN | 196 | Q9UPN4 | |
| KNDKPLPSATARPNT | 1136 | O43432 | |
| NKNSLVSPAQEPAPL | 346 | Q13555 | |
| ETRSNETQNPHKPSP | 486 | Q96LW4 | |
| AVPKAENPSRTQVPS | 551 | Q9P2P1 | |
| ENPSRTQVPSAAPKL | 556 | Q9P2P1 | |
| QSRAPSKQPPAGNVA | 636 | Q9Y283 | |
| PPSAPRNVVFNINET | 331 | Q9UF33 | |
| DNEAPPKVPQRTSSI | 661 | Q8N4C8 | |
| PQKPRRSPNTQLSVS | 161 | Q6ZVC0 | |
| PQLEQENIKSSSPPS | 231 | Q14995 | |
| QAAAPASVPAQAPKR | 136 | P47914 | |
| ASVPAQAPKRTQAPT | 141 | P47914 | |
| SRTQQPAPLAAPAAQ | 726 | Q8N2Y8 | |
| SPKRVVQAAPPAAQT | 346 | O00268 | |
| SQSVSPSKQAAPRPA | 866 | Q12872 | |
| ASTPPASKENNVSQP | 106 | Q02446 | |
| NAATISQPPDRQSEP | 461 | Q96KN7 | |
| LQPKPSSQPRAQRHS | 996 | A5PKW4 | |
| NLKSSDRNPPLSPQS | 236 | Q9P270 | |
| EPSPVNSHPQRSDKN | 101 | Q06210 | |
| FQKSPQNHRPPSVSD | 1291 | Q9UFD9 | |
| RDKAPVQPQQSPAAA | 6 | Q13200 | |
| SQQYATQTDKRPPPP | 266 | Q9HCM1 | |
| DSPAQQLKSPFQPVR | 446 | P78414 | |
| NTSDSEQAQKPVSPP | 141 | Q9NQW5 | |
| VSPSDQRNPKNNVVP | 511 | Q15678 | |
| KPLSRPQQSSAPVQL | 241 | Q96HL8 | |
| PSPKTNNAFPQQRIL | 581 | Q1XH10 | |
| PEKETPSLNPLAQSQ | 741 | Q1XH10 | |
| LPASQTPASNQPKRP | 111 | P48634 | |
| PQRKSRTPENQQFPD | 411 | P0CG39 | |
| QEPGAQPFSPKNIRS | 716 | O43166 | |
| NQKAPLPCPQQDVSR | 181 | Q8NDZ2 | |
| QPAKAQIVRSNQPSP | 1606 | Q9HCD6 | |
| ASDPQSPPQVSRHKS | 416 | Q7L7X3 | |
| NPLPSKDQPSSPRQT | 2106 | Q9P2P6 | |
| TPKNFPDPHRSINRQ | 821 | Q8NHU6 | |
| PTQNEPFLRTPRNSN | 1041 | Q6P1J6 | |
| NPRNSSPHRTNKDIP | 891 | Q9H2D6 | |
| KTRENVPNSDSQPPP | 176 | Q8IY92 | |
| RQSRPANKQSPSPSE | 66 | P55201 | |
| ANKQSPSPSEVSQSP | 71 | P55201 | |
| PPRKDLPDSQQQHQS | 326 | P25440 | |
| RKAAQPKSLSPPQSQ | 316 | Q9UQB8 | |
| RPSQIPTPVNNNTKK | 2801 | P25054 | |
| NQPPSKSTIRPKNDV | 46 | Q8IYA6 | |
| TQPRIPSTDTQVQPK | 326 | Q9ULV3 | |
| PRSQQENPESQPQKR | 856 | O94762 | |
| ENPESQPQKRPRPSA | 861 | O94762 | |
| GPNLAPTSRDQKQEP | 156 | Q15735 | |
| PQPSSSSRQRQQQPK | 1651 | Q7KZ85 | |
| QKSEIHRANTSPSPP | 2986 | A4UGR9 | |
| LAKRKPPTANNSQAP | 346 | Q9UKI8 | |
| KSQPEPSPVLSQLSQ | 426 | Q5T6F2 | |
| QPSSLQPKSQASKPA | 1096 | Q5T6F2 | |
| TGSSRPQSQPEPNKV | 821 | Q9ULJ3 | |
| EQPQSISKDLNSPGP | 851 | P17040 | |
| NRTAKPFPGSVNQPA | 586 | Q9UMS6 | |
| QATFQQLQKPPSPAR | 1131 | Q99973 | |
| VKNPSPALPTANNTV | 106 | Q96EK2 | |
| AQKPRPSSGNLLQSP | 1081 | Q96PV0 | |
| SSQPRQAPASPQEAA | 176 | Q9BW04 | |
| QAPKTRSLDFPQNEP | 361 | Q8NEF9 | |
| EPTQTLASRPRKHPQ | 706 | Q96PX9 | |
| AICPPQNTENQRPKT | 1006 | O75717 | |
| PDSNSTQLKTPQVSP | 1166 | Q96K83 | |
| PLSQQSQLPPKRDET | 241 | O14964 | |
| ASPGNPPDRQNSKLA | 181 | Q9NW97 | |
| KPPSNAQDLPRNQKE | 201 | Q9UHP3 | |
| QQSERTPNNRPDAPK | 536 | Q9BVJ6 | |
| NSFQPQVKTLPSPID | 191 | Q2KHR2 | |
| KRPSCAPSPQDLSAQ | 61 | O75678 | |
| QPFPQQPSVKATDSD | 4096 | Q86WI1 | |
| QAPASFLVQKSPPRN | 261 | A6NFE2 | |
| PAAISQQNPPKNREA | 126 | Q9BQ87 | |
| PDNCRLVPNPNQKDS | 676 | P49746 | |
| SEVSPNSKPSPNTKN | 76 | P12272 | |
| AANPKPERAQSQPES | 936 | Q9BZ71 | |
| PQPTNLATPNTKRFK | 566 | P54278 | |
| QAPVSHNSKDPPARQ | 1281 | Q96JG9 | |
| ANVKPRNSTPPSLAR | 236 | Q96GY0 | |
| KPASQQKAEASSPVP | 916 | Q07157 | |
| EPQERNSSPQRPAVS | 56 | P0CG23 | |
| QPQSPDFLDITNPKA | 126 | Q92890 | |
| KSVPNTPLRPNQQSV | 1841 | Q15643 | |
| PPSTKPFQEAQSELN | 1231 | Q9Y4G6 | |
| TPSNPNSPSAQLAKE | 96 | Q8NET8 | |
| SSPQPQQKAPRAIDS | 411 | O60346 | |
| PPTSQNTTARNPRKS | 541 | Q8ND82 | |
| PKSQDSVSSPSPQKQ | 1101 | Q70CQ4 | |
| ATKIQIPRPDDPSNQ | 181 | Q00341 | |
| PAKQPLQQAAPSDSD | 1211 | Q502W6 | |
| DNTPSSPSQVAARPK | 211 | Q9H0M0 | |
| TPAKRPALQDSNLAP | 1881 | Q12789 | |
| PLAQKRNQKATPNSP | 606 | Q96LC7 | |
| SAQTSNSELPPKPAA | 276 | Q6N021 | |
| ALSQSQEPPPSVNRV | 366 | Q9H347 | |
| PNLDKKNTPVQSPVS | 341 | O95071 | |
| SQTQSRRPHPLKPQD | 486 | Q49AM3 | |
| NQFQSDPPAPSDKSV | 106 | Q9NRV9 | |
| RSNSPKTKQEIDPPN | 771 | Q96L42 | |
| APKPVAAATPVSQQA | 856 | O15069 | |
| APKPVAAATPVSQQA | 896 | O15069 | |
| AAIFTPPAQDPKNVR | 416 | Q6PIF6 | |
| ISLPTPQNTPKEANQ | 1676 | Q5VU43 | |
| NRIQKPNEVSSPPTT | 376 | Q86TC9 |